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CARDIOLOGY
DUAL ISOTOPE F-18 FDG AND TC-99M MIBI MYOCARDIAL SPECT
IN PATIENTS WITH HODGKIN'S DISEASE AFTER CHEMO-AND MANTLE
RADIOTHERAPY
I. Garai, Á. Illés, J. Varga, B.C. Kiss, L. Szabados, K. Szluha, L. Galuska
University of Debrecen, PET-CT Medical Diagnostic Ltd., Debrecen, Hungary
Aim: We evaluated myocardial perfusion and metabolism years after this combined
treatment for Hodgkin's disease had been applied.
Material and methods: 30 patients with Hodgkin's disease (HD) with a mean age
of 46.4 were studied (16 females, 14 males). All of them were treated with mantle
radiotherapy [only mantle or (sub)total nodal irradiation] and chemotherapy at a
mean of 15.5 (8–26) years ago. 30 healthy patients with normal myocardial blood
flow made up the control group. Patients with HD underwent F-18 FDG/Tc-99m
MIBI DISA SPECT. In the control group only the myocardial perfusion was assessed.
Results were evaluated using a dedicated quantitative myocardial perfusion pro-
gram package (ACSP-2, Elscint). Quantitative polar maps were generated both from
the perfusion and metabolic images. From the polar map the average activities of
16 regions were expressed as the percentages of the highest activity.
Results: In patients with HD the basal segments and two inferoapical segments of
the myocardium had significantly lower perfusion values compared to those of healthy
patients (P < 0.0001; Bonferroni corrected significance level: 0.0032). Neverthe-
less, the metabolism of these segments was preserved and it did not differ signifi-
cantly from that of the other segments.
Conclusions: On the basis of our results we can conclude that combined modality
therapy decreases the perfusion of basal myocardial segments, but does not affect
the glucose metabolism of these heart muscle cells. Finally, we advise the cardio-
logic follow-up of patients with HD.
WHAT IS THE IMPORTANCE OF FUSED IMAGES OF PET-SPECT-CT-CT
CORONARY ANGIOGRAPHY AFTER AMI AND REVASCULARISATION
IN MULTIVESSEL DISEASE?
I. Balogh1, Z.S. Lengyel2, G. Kerecsen3, G. Nemeth4, I. Preda5
1Uzsoki Hospital, Budapest, Hungary
2Pozitron Diagnostic Ltd., Budapest, Hungary
3National Center of Health, Budapest, Hungary
4Mediso Ltd., Budapest, Hungary
5National Center of Health, Budapest, Hungary
Aim: Sought the diagnostic advantages of multimodality and fused images by PET/CT and SPECT
and CT coronary angiography (MSCT) in pts with multivessel diseases after myocardial infarction
(AMI) and revascularisation procedures (ACBG, PCI). What is the diagnostic importance of simul-
taneous physiological (perfusion-SPECT and metabolism-PET) and anatomical (MSCT) informa-
tion: 1 — to decide the effectiveness of revascularisation (open or restenosed arteries), 2 — to
detect the “culprit lesion” i.e. which coronary artery is responsible for ischaemia?
Material and methods: In 10 cases after AMI and revascularisation procedure (5 patients with
PCI, 5 patients with ACBG) in multivessel diseases were analysed the results of F-18-FDG
PET/CT (Siemens Biograph) and Tc-MIBI gated SPECT (Mediso-CardioSPECT D90) exami-
nations fused images. For image fusion PMOD 2,75, for 3D display MIP and volume rendering
(VolView 2,0), for SPECT reconstruction InterWiew XP1.04 (Mediso Ltd.) were used. We eval-
uated the myocardial viability analysing PET-SPECT matching (non-viable) or mismatching
(viable).
Results: After PCI we could in one case (1/5 patients) find by SPECT-PET fused images
a large “scare”, without ischaemia (SPECT-PET fused images, “matching”) and by MSCT
open arteries without restenoses, in two cases (2/5 pts) restenosed arteries (MSCT) and se-
vere ischaemia (SPECT-PET fused images, “mismatching”) in the field of restenosed arteries.
After ACBG 4/5 cases the grafts were open, non-stenosed by MSCT and without ischaemia
on SPECT-PET fused images. In the case of stenosed graft (1/5) severe ischaemia (“mis-
match”) was verified on SPECT-PET fused image.
Conclusion: Our preliminary results by PET-SPECT-MSCT fused multimodality images could
give through the simultaneous physiological (SPECT-PET) and anatomical (MSCT) informa-
tions about the effectiveness of revascularisation procedure, the most accurate diagnosis
of restenosed arteries and their authentic place in AMI patients with multivessel disease after
revascularisation procedures ie PCI and ACBG.
ASSESSMENT OF MYOCARDIAL VIABILITY AND PERFUSION WITH
FDG-PET AND MIBI-SPECT AFTER TRANSPLATATION OF PROGENITOR
CELLS IN ACUTE MYOCARDIAL INFARCTION
Z. Hascsi1, L. Balogh2, L. Balkay3, J. Varga3, Z. Barta1, L. Szabados1, I. Garai1,
L. Galuska3
1PET-CT Medical Diagnostic Ltd., Hungary
2Department of Cardiology, Medical and Health Science Center, University of
Debrecen, Debrecen, Hungary
3Department of Nuclear Medicine, Medical and Health Science Center, University
of Debrecen, Debrecen, Hungary
Aim: The aim of the present study was to evaluate the effects of intracoronary infused
bone marrow derived progenitor cells (CD34+) on regional myocardial viability and
perfusion in patients with first episode of acute myocardial infarction.
Material and methods: Seven patients were treated by percutaneous revasculari-
sation and stenting of the occluded artery; 6 left anterior descending (LAD), 1 right
coronary artery (RCA). All patients received intracoronary infusion of autologous
CD34+ bone marrow stem cells 12 ± 1 days after the revascularisation. All patients
underwent FDG-PET and MIBI-SPECT before transplantation and 6 months after-
wards during follow-up. For quantitative evaluation of myocardial [18F]FDG and
[99mTc]MIBI uptake a ventricular segmentation scheme (16 segments) was applied.
Mean signal intensities (MSI) of the segments assigned to the LAD/RCA distribution
were calculated for each patient.
Results: PET studies showed a highly significant increase of the MSI in the infarct
area from 56.6 ± 11.8% to 72.2 ± 13% (p = 0.007). No statistically significant
differences were found in myocardial [99mTc]MIBI uptake before (52.8 ± 10.3%) and
after (59.0 ± 15.9%) stem cell transplantation(p = 0.152).
Conclusion: Our results indicate that local intracoronary CD34+ progenitor cell
therapy results in a significant increase in myocardial viability of the infarct zone.
TRUE "FALSE POSITIVE" MYOCARDIAL SCINTIGRAPHY?
THE DILEMMA OF PATIENTS WITH POSITIVE MYOCARDIAL SCINTIGRAPHY
AND NORMAL CORONARY ANGIOGRAPHY
Monika Moravszki1, Klara Buga1, Zoltan Nagy1, Zsolt Varga1, Robert Gabor Kiss2,
Istvan Szilvasi1
1Department of Nuclear Medicine, National Medical Center, Budapest, Hungary
2Department of Internal Medicine, National Medical Center, Budapest, Hungary
Aim: Clinical data of patients with high clinical probability of ischemic heart disease
(IHD) with reversible perfusion defect on stress myocardial perfusion scintigraphy (MPS)
but without significant coronary artery stenosis on coronary angiography (CAG) were
retrospectively analysed.
Material and methods: 618 patients with reversible perfusion defect on MPS and
sent to CAG within two months were studied. Tc-99m-tetrofosmin MPS (one-day
protocol, 400 + 700 MBq) was performed and semiquantitatively evaluated. 53 out
of 618 patients had no significant stenosis on CAG. Correlation between clinical
findings and abnormal MPS were analysed in this group of patients.
Results: 35 out of 53 patients had typical, 15 had atypical angina, 3 had dilatative
cardiomyopathy (DM). 44 patients had hypertensive disease (HD), 14 had non-
insulin-dependent diabetes mellitus (DM). 13 had both HD and DM. The final clini-
cal diagnoses were: 36 patients had IHD. 13 had HD (5 of them also had DM),
1 had DM, 2 had hyperlipidemia. In 1 patient diagnosis was “sine morbo”, this
patient had “true” false positive MPS.
Conclusions: In patients with high clinical probability based on demographic data
and risk factors of IHD, positive stress MPS can reflect impairment of myocardial
perfusion even if CAG is negative. This can be explained in large majority of patients
by microangiopathy associated with HD and/or DM.
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ONCOLOGY AND SENTINEL NODE
NITROGLYCERIN-AUGMENTED TC-99M-TETROFOSMIN MYOCARDIAL
SCINTIGRAPHY IS A SUBSTITUTE FOR REST TL-201 SCINTIGRAPHY?
Z. Nagy1, Z. Varga1, K. Buga1, E. Takács2, A. Radácsy2, I. Szilvási1
1Department of Nuclear Medicine, National Medical Center, Budapest, Hungary
2Department of Nuclear Medicine, Semmelweis University, Budapest, Hungary
Background: Nitroglycerin-augmented myocardial scintigraphy at rest with Tc-99m-
-labelled perfusion agents (NG-Tc) and rest-redistribution Tl-201 myocardial scin-
tigraphy (Tl) are widely used to visualize jeopardized but viable myocardium.
Aim of our study was to compare NG-Tc and Tl in post-infarction patients with fixed
perfusion defects on stress-rest Tc-99m-tetrofosmin myocardial SPECT.
Material and methods: Stress-rest Tc-99m-tetrofosmin SPECT were performed
using one-day protocol. Resting injection was given after sublingual nitroglycerin
administration. Patients with at least one large fixed defect underwent a Tl SPECT
(images at 20 minutes and 3 hours) within 4–14 days. NG-Tc and Tl scintigrams of
49 patients were compared semiquantitatively using a 13-segment model and scor-
ing system of 0–3 scores (0: normal, 3: absent perfusion).
Results: 180 out of 637 segments showed fixed perfusion defect on NG-Tc scintig-
raphy. 45 of them showed improved Tl-201 uptake, 9 had lower Tl uptake. Mean
segmental score were 1.58 ± 1.01, 1.76 ± 1.06 and 1.78 ± 1.06 on NG-Tc, rest-Tl
and delayed-Tl scans respectively, showing significant (p < 0.01) increase of rela-
tive uptake on both Tl-201 images.
Conclusions: Myocardial segments with fixed perfusion defect on NG-Tc SPECT
have more uptake with Tl-201. Rest-redistribution Tl SPECT can not be substituted
by NG-Tc SPECT in postinfarction patients.
PREDICTIVE VALUE OF STRESS TC99M-TETROFOSMIN GATED AND REST
— REDISTRIBUTION TL-201 MYOCARDIAL PERFUSION SPECT BEFORE
NON-CARDIAC SURGERY
E. Takács1, M. Janecskó2, Z. Varga1, A. Radácsi1, I. Szilvási1
1Department of Nuclear Medicine, Semmelweis University, Kútvölgyi Clinical
Center, Budapest, Hungary
2Department of Anaesthesiology and Intensive Care Unit, Semmelweis University,
Kútvölgyi Clinical Center, Budapest, Hungary
Aim: To determine the perioperative cardiac risk in patients for non-cardiac surgery
by Tc99m-tetrofosmin gated myocardial perfusion SPECT.
Material and methods: Tc-99m-tetrofosmin stress myocardial perfusion SPECT
and gated SPECT in rest (GSPECT) were performed in 100 randomly chosen pa-
tients with intermediate risk for coronary artery disease preoperatively. In case of
fixed defect (36 patients), additional Tl-201 rest-redistribution perfusion SPECT was
also performed.  Perioperative myocardial ischemia (PI) was detected by continu-
ous monitoring.
Results: Patients were divided into 5 groups: I. normal findings, II. reversible defect
with EF > 45%, III. reversible defect with EF < 45%, IV. fixed defect with EF > 45 %,
V. fixed defect with EF < 45%. PI was detected in 13 patients. In group I (n = 23) no
PI was found. PI occurred in 1 patient of group II (n = 24) and in 8 patients of group
III (n = 17). In group IV (n = 21) no PI was observed. In 4 patients of group V
(n = 15) PI was detected, all of them had Tl-201 uptake in the fixed defect.
Conclusions: Our results prove the predictive value of GSPECT in perioperative
risk stratification. Patients having low EF (< 45%) and reversible perfusion defect or
fixed defect with viable myocardium have high risk of PI.
MULTIVARIATE ANALYSIS OF MYOCARDIAL SPECT POLAR MAP IMAGES
K. Zupán1, B. Kári2, O. Pártos3
1Department of Cardiology, Semmelweis University, Budapest, Hungary
2Department of Diagnostic Radiology and Oncotherapy, Semmelweis University,
Budapest, Hungary
3Gottsegen György Hungarian Institute of Cardiology, Budapest, Hungary
Aim: Quantitative evaluation of myocardial SPECT (MS) studies is usually based
on comparison to a gender-specific reference database. However, there may also
be further factors that influence the regional activity distribution, apart from coro-
nary artery disease (CAD). We present the framework of a statistical evaluation
approach for MS studies that can account for the effect of several such confound-
ing factors simultaneously.
Material and methods/Results: A reference database was developed on 58 pa-
tients without angiographic CAD, undergoing a 2-day stress-rest tetrofosmin MS
study. The regional effect of various clinical and imaging variables was analyzed
by univariate and multivariate linear regression for the polar map segmental values.
Gender, body weight, hypertension, hypercholesterolemia, left ventricular ejection
fraction, resting systolic blood pressure and heart rate at radiopharmaceutical
injection were found to be independent predictors of the regional count density.
The utility of the method was assessed on MS studies of 85 patients with angio-
graphic CAD.
Conclusions: The left ventricular activity distribution in MS images is influenced
by various factors beyond myocardial ischemia. Accounting for these effects with
a multivariate prediction model may enhance the accuracy of the diagnosis of CAD.
ONCOTHERMIA (ELECTRO-HYPERTHERMIA) I. FIRST RESULTS
IN ONCOTHERMIA BASIC RESEARCH
G. Andocs1, A. Szasz2, L. Balogh1, D. Mathe1, A. Polyak1, G.A. Janoki1
1Department of Applied Radioisotopes, National Research Institute
for Radiobiology and Radiohygiene, Budapest, Hungary
2Faculty of Engineering, St. Istvan University, Gödöllõ, Hungary
Aim: Hyperthermia applications for cancer therapy has been documented for thou-
sand years. Since then numerous hyperthermia methods were developed including
energy delivery by electric field, but the exact mechanism of action of the oncolog-
ical electro-hyperthermia is still the subject of the scientific debate and the method
is not widely accepted by oncologists. In our present work we had compared the
effects of two hyperthermia methods in vivo and in vitro models: the classical heat
delivery versus capacitively coupled electro-hyperthermia. Both methods were also
compared to an untreated control.
Material and methods: The in vitro test system was a human hepatocellular carci-
noma cell line (HepG2) grown onto the surface of a thin glass coverslips. The in vivo
model was a tumor bearing Nude mice, the tumor was originated from HepG2 and
HT29 cell lines. The electro-hyperthermia device was a 13.56 MHz sinus wave ra-
diofrequency generator. The energy transfer was carried out by capacitive cou-
pling, the treated sample was placed between a specially designed condenser elec-
trodes. The classic heat delivery method was done by a thermo-regulated hotplate
in case of the in vitro system and an infra red emitter in case of nude mice. The
heating dynamics and the total hyperthermia time of the treated samples was kept
identical in both hyperthermia method. Permanent temperature monitoring was done
using a fluoroptic temperature measurements system (Luxtron).
Results: Significant differences were observed in cell viability, cell morphology and
tumor tissue structure compared untreated control to electro-hyperthermia treated
samples vs. samples treated with heat alone. Also significant differences were de-
tected between the treatments in apoptotic pattern and different immunohistochem-
ical properties (beta-catenin and HSP70 distribution).
Conclusions: Our present preliminary results indicate that extensive further research
is needed to clarify the basic principles and mechanisms of action of electro-hyper-
thermia to became a widely accepted and scientifically proven tumor treatment
method, as well as an effective supportive treatment for isotope-therapies.
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ONCOTHERMIA (ELECTRO-HYPERTHERMIA) II. EFFECT
OF ELECTRO-HYPERTHERMIA TO THE TUMOR UPTAKE OF CERTAIN
RADIOPHARMACEUTICALS — FIRST PILOT STUDIES
G. Andocs1, A. Szasz2, L. Balogh1, D. Mathe1, A. Polyak1, G.A. Janoki1
1Department of Applied Radioisotopes, National Research Institute for
Radiobiology and Radiohygienie, Budapest, Hungary
2Faculty of Engineering, St. Istvan University, Gödöllõ, Hungary
Aim: The complete mechanism of action of electro-hyperthermia involves many
effects which could affect the radiopharmaceutical uptake of certain tumors. The
most important interactions are expected in the phenomena of the thermophoresis,
in the thermodiffusion and in the relatively less investigated electo-endocytosis.
In our present study the distribution changes of different 99mTc-labelled radiophar-
maceuticals (99mTc-DMSA(V), 99mTc-MDP, 99mTc-Liposoma) were investigated by the
action of electro-hyperthermia treatment in in vivo model.
Material and methods: The experimental animal was a tumor bearing nude mice
xenograph model. In vitro cultivated HepG2 (human hepatocellular carcinoma) and
HT29 (human colorectal cancer) cells were used to induce a tumor. Two separated
tumors were induced in each mouse by injecting subcutaneously the tumor cell
suspension to the femoral region both sides. To make the comparison accurate,
only those animals were used for the studies, which had symmetrically grown tu-
mors in the same size. Right after the intravenous injection of radiopharmaceuticals
one of the tumors of the experimental animal was treated by electro-hyperthermia
for 30 minutes, the other lesion was the untreated control. During the treatment
permanent temperature monitoring was performed using a fluoroptic temperature
measurement system (Luxtron). The achieved temperature was 42–43°C in the treat-
ed tumor while it remained 36–37°C in the control tumor. The radiopharmaceutical
uptake in the tumor was measured by a nanoSPECT/CT dual modality imaging
system recently developed by the Mediso-BioScan. The quantitative analysis of the
radiopharmaceutical uptake in the tumor was measured by standard voxel analysis.
Results: We found that due to the effect of electro-hyperthermia the radiopharma-
ceutical uptake in all the cases was higher in the treated tumor compared to the
untreated identical control on the same animal. In case of 99mTc-Liposoma the gain
was significant (30–40%), [p < 0.05]; while the similar increase was smaller in the
case of 99mTc-DMSA(V) (10–15%).
Conclusions: According to the present advantageous results we found a definite
enrichment of 99mTc-labelled radiopharmaceuticals in vivo by effect of electro-hy-
perthermia. Our present investigations show that a large-scale cooperative research
is required to develop an effective tumor therapy methods based on this revealed
effect.
THE IMPORTANCE OF SENTINEL LYMPH NODE DETECTION
IN PROSTATIC CANCER
E. Boda1, I. Balogh1, J. Varga2, A. Páczelt2, K. Pócza3
1Department of Nuclear Medicine, Uzsoki Street Teaching Hospital,
Budapest, Hungary
2Department of Urology, Uzsoki Street Teaching Hospital, Budapest, Hungary
3Department of Pathology, Uzsoki Street Teaching Hospital, Budapest, Hungary
Background: The lymph node (LN) metastases of prostate cancer (PC) can be
found most frequently in standard 4 regions. The probability of metastatic cases are
estimated on the basis of predictive nomograms. Is there any advantage of the
sentinel lymph node detection (SLN) comparing these informations.
Material and methods: SLN detection where performed in 59 cases (mean age:
61 ± 10 years, clinical stage: T1c-2 N0M0, PSA: 9.54 ng/ml). 200 MBq Tc-99m
SentiScint was injected into prostate. After 3 and 24 hours static (AP, PA, LLAT,
RLAT views and sitting positions) pictures, in 12 cases SPECT examinations were
performed as well. During the operation g-probe was used for the detection of SLN.
The removed SLN-s where analyzed histopathologically as well.
Results: During lymphoscintigraphy SLN could be found every case, the number
of it was > 2 in 45/59 cases. The SLN were found in 2/59 cases (3%) outside
the standard regions. With pathological examinations metastases were diagnosed
in 10/59 pts (17%).
Conclusions: The results of SLN examination (lymphoscintigraphy + SLN detec-
tion and removing with g-probe + histopathological examination) proved to be use-
ful method in the treatment of pts with PC, comparing the estimated probability of
metastases with predictive nomograms (17% versus 2–3%) and the standard re-
gional localisation of metastases (in 3% of pts outside these regions!).
STUDIES ON OCTREOTIDE GROWTH INHIBITION EFFECTS IN DAOY
MEDULLOBLASTOMA CELL CULTURE AND MOUSE XENOGRAFT MODEL
D. Máthé1, L. Balogh1, A. Polyák1, G. Jánoki1, P. Hauser2, F. Schuler2, M. Garami2,
F. Tímár3, A. Jeney3, Z. Hanzély4, E. Szabó5
1Department of Applied Radioisotopes, Research, National Frédéric Joliot-Curie
Institute of Radiobiology and Radiohygiene, Budapest, Hungary
22nd Department of Pediatrics, Semmelweis University, Budapest, Hungary
31st Department of Pathology and Experimental Cancer Research, Semmelweis
University, Budapest, Hungary
4National Institute of Neurosurgery, Budapest, Hungary
5Faculty of Arts, Debrecen University, Debrecen, Hungary
Aim: Potential antiproliferative effect of octreotide, a somatostatin analogue was
tested on amedulloblastoma cell line in tissue culture and in SCID mice.
Material and methods: DaOY medulloblastoma monolayer cell culture was treated
for 72 hours with octreotide, alone and in combination with cisplatin, etoposide,
vincristine, irinotecan. For combined treatment the lowest effective dose of octreotide
was applied (2.5 mM). SSTR2 positive DaOY medulloblastoma xenograft was
established in SCID mice and treated with octreotide (20 and 100 mg/kg/day)
subcutaneously for 10 consecutive days). Xenografts were scanned with the oct-
reotide analogue 99mTc-HYNIC-TATE peptide gamma scintigraphy.
Results: 99mTc-HYNIC-TATE peptide scintigraphy could identify xenografts.
50% inhibitory concentrations (IC50) were 1.2 mM for cisplatin, 0.0007 mM for vincris-
tine, 5.8 mM for irinotecan, 0.7 mM etoposide and 22 mM for octreotide. High dose
octreotide (44 mM) achieved more than 90% inhibition. In combination octreotide
(2.5 mM) partially antagonized the antiproliferative effect of vincristine in monolayer
cell culture.
Conclusion: Octreotide is an effective drug in DaOY human medulloblastoma,
investigated both in cell culture and in xenograft model. However, the effective drug
concentration exceeds conventional clinical dosage.
This work was supported by OTKA T-46938, NKFP 1A/002/2004 grants and EMIL
Network of Excellence (EC-FP6).
SUCCESS RATE OF RADIOGUIDED SENTINEL LYMPH NODE BIOPSY
IN DIFFERENT BREAST TUMOURS BY INTRATUMOURAL RADIOCOLLOID
ADMINISTRATION
M. Lázár1, G. Lázár3, T. Takács3, Z. Besenyi1, T. Séra1, M. Papós1, K. Ormándi1,
R. Hajnal-Papp5, E. Szabó1, T. Mikó5, A. Palkó4, L. Pávics2
1Euromedic Diagnostics Szeged Ltd., Hungary
2Department of Nuclear Medicine, University of Szeged, Szeged, Hungary
3Department of Surgery, University of Szeged, Szeged, Hungary
4Department of Radiology, University of Szeged, Szeged, Hungary
5Department of Pathology, University of Szeged, Szeged, Hungary
Background: Radioguided occult lesion localization (ROLL) and simultaneous sen-
tinel lymph node (SN) biopsy are routinely performed in our department.
Aim: To assess the feasibility of radioguided SN biopsy using intratumoural radio-
colloid administration and to investigate, whether the tumour histology had an im-
pact on the success rate of the procedure.
Material and methods: Two hundred and sixteen women with non-palpable breast
lesions were enrolled into the study. The radiopharmaceutical (99mTc-Senti-Scint)
was injected intratumourally under US or X-ray guidance the day before surgery.
Four hours later SN mapping, the next day open surgical tumour excision and axil-
lary SN biopsy were carried out by using a gamma probe and blue staining guid-
ance.
Results: Invasive tumour was found in 161 patients (group A), only DCIS was
detected in 39 cases (group B) and the tumours were proved to be benign
in 16 cases (group C). Axillary SNs were detected by radioguidance in 88%
(142/161) of group A, in 90% (34/39) of group B and only in 69% (9/16) of group C
patients. Axillary SN was detected only by blue staining in further 9, 1 and 3 cases
respectively.
Conclusion: Our method is suitable for the detection of SN in patients with malig-
nant breast tumours but it is less effective in benign lesions, which is evidently irrel-
evant being conscious about the definitive histopathological findings.
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SENTINEL LYMPH NODE SCINTIGRAPHY (SNC) IN THE PRE-
AND PERIOPERATIVE DIAGNOSIS OF BREAST CANCER
E. Schmidt1, Z. Szabó1, G. Szalai2, E. Kálmán3, G. Tizedes4, G. Pavlovics4,
K. Zámbó1
1Department of Nuclear Medicine, University of Pécs, Pécs, Hungary
2Department of Radiology, University of Pécs, Pécs, Hungary
3Department of Pathology, University of Pécs, Pécs, Hungary
4Department of Surgery, University of Pécs, Pécs, Hungary
Background: The importance of SNC in the perioperative diagnosis of breast can-
cer is well-known. Using the method with further completitions, results useful addi-
tional informations.
Aim: To establish, how these informations influence the treatment and manage-
ment of the patients.
Material and methods: 100 women were observed whose breast cancer was proved
by fine needle biopsy (FNB). SNC was performed a day before the planned opera-
tion. The radiopharmaceutical (80 MBq 99mTc-Senti-Scint) was injected peritumor-
al, in 4–8 portions, using US guide. Anterior and lateral planar scans were per-
formed 1 and 3 hours after the injections from the chest and axilla. The projections
of the SN were marked on the skin. With help of this markers US guided FNB
and cytology of SN was performed in 71 cases. The operation was carried out
the next day with removing of SN and low axillary blockdissection,  or — in cases
of metastatic laesions — total axillary blockdissection.
Results: The peritumoral administration of the radiopharmaceutical supports the
surgeon to the adequate removing of the tumor, especially in non palpable tumors
(ROLL technic). The preoperative SN biopsy showed metastatic laesions in 10 pa-
tients. The histological examination verified lymph node metastasis in 27 cases, but
the SN was positive only in 14 cases.
Conclusions: The US guided peritumoral administration and preoperative FNB of
SN are valuable completitions in the surgical therapy of the breast cancer, helping
in the selection of the appropriate surgical procedure. If the metastasis involves
only the SN to perform of total axillary blockdissection is considered by using of the
low axillary blockdissection.
POSTOPERATIVE  FOLLOW-UP OF 300 BREAST CANCER PATIENTS
WITH NEGATIVE SENTINEL NODE BIOPSY
M. Sinko, M. Rajtar, G. Cserni1, Boross2, E. Tekle Wolde, E. Ambrozay3
1Departments of Nuclear Medicine and Pathology, Bács-Kiskun County Hospital
Kecskemét, Hungary
2Department of Surgery, Bács-Kiskun County Hospital Kecskemét, Hungary
3Mamma Clinic
Aim: In a previous study we detected 1 axillary recurrence in 292 breast cancer
patients with negative sentinel node biopsy (SNB) and no axillary  lymph node dis-
section (ALND) during a mean of 27.2 months follow-up period. The aim of our
present study is to investigate the rate of axillary recurrence in a longer follow-up
period.
Material and methods: Between October 2000 and Augustus 2005 selective ALND
was performed in 517 consecutive patients with a T1 or T2 breast cancer and clin-
ically negative axillary nodes, i.e. ALND was omitted in patients with negative senti-
nel node (SN) biopsy. SN(s) were identified using a combined labelling method:
Tc99m -labelled nanocolloid was injected peritumorally on the day before the oper-
ation and vital blue dye was injected above the tumor just before the operation. Only
hot and/or blue lymph node(s) were declared as SN(s) during surgery. ALND was
omitted in 323/517 patients on the basis of a negative intraoperative imprint cytolo-
gy and postoperative hematoxylin-eosin (HE) and cytokeratin immunohistochemis-
try stained sections of SN(s). 300/317 patients were followed-up: the mean of fol-
low-up time was 36.45 months (range 9–73 months). In 140/300 patients (46.6%)
the follow-up time was 37–73 months.
Results: Axillary recurrence was found in 2/300 patients (0.66%) 11 and 23 months
after the operation. In 3/300 patients (1%) local recurrence, and in 12 patients (4%)
distant metastases occured in a mean of 23 months after the primary treatment.
Conclusions: During a longer follow-up period only 1 further axillary recurrence
was detected in the same patient group. The rate of axillary recurrence (< 1%) is
similar or lower as compared to the data published by experienced authors (Vero-
nesi [2005]: 0.3%, Roumen [2001]: 1%, Krokke [2005]: 0.88%). Our results confirm
that 1. using strict patient enrollment, 2. using combined radiocolloid and blue dye
labelling technique 3. and a collaboration of a properly trained team (nuclear med-
icine, surgery, pathology) SN biopsy without ALND in SN-negative patients is
a reliable staging procedure with a low axillary recurrence rate.
FOLLOW UP OF IMATINIB THERAPY WITH FDG PET/CT IN GIST:
A CASE STUDY
S. Szakáll, P. Molnár, G. Tóth, Z. Lengyel
Pozitron Diagnostics Ltd., PET/CT, Budapest, Hungary
In 2000, the patient underwent extended total gastrectomy due to not healing ulcer
and positive biopsy resulting stromal tumor. The histology was a gastrointestinal
stromal tumor (GIST) of fibrous subtype with strong c-KIT (CD117) positivity
and high mitotic rate. In 2002 multifocal recurrence of the disease was proved by
imaging and core biopsy. PET/CT examination performed in Germany showed high
tracer uptake in the lesions and the disease was declared inoperable. The imatinib
therapy started in June 2002 with 400 mg daily dose. Structural imaging performed
during the follow-up revealed incomplete regression, and later stable disease.
In July 2005 PET/CT scan done in our institute showed complete metabolic remis-
sion. The patient stopped the therapy in January 2006. The repeated PET/CT scan
in august demonstrated the growth of the lesions and the appearance of patholo-
gical tracer uptake. The therapy was restarted shortly after the examination.
The next scan in January this year again proved complete metabolic regression.
Negative FDG PET scans in patients with GIST indicate tumor control rather than
tumor free state during the imatinib therapy.
ADRENAL METASTASIS OF PULMONARY MICROCELLULAR CARCINOMA
ON BONE SCAN
E. Udvaros, E. Schmidt, Z. Szabó, K. Zámbó
Department of Nuclear Medicine, University of Pécs, Pécs, Hungary
Background: 54 year old woman with pulmonary carcinoma was examined by bone
scintigraphy. High radiopharmaceutical uptake had shown in the left upper lumbar
region. Localisation of the hot spot was uncertain: XII rib or the upper part of the left
kidney.
Aim: Exact localisation of the hot spot.
Material and methods: Images were acquired after intravenous injection of 800
MBq Tc99m-MDP by gamma camera. After planar examination Furosemide was
administered. For further examination SPECT imaging of the lumbar region was
proceed by Siemens Multispect II.
Results: After the administration of diuretic material the hot spot did not show any
changing. The upper part of the left kidney showed by SPECT imaging. Adrenal
metastasis was also verified by CT examination.
Conclusion: Calcification of primary malignancy or metastases may appear on bone
scan.
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CLINICAL USEFULNESS OF TC-99M-SESTAMIBI SCINTIGRAPHY
IN MULTIPLE MYELOMA
Z. Varga1, Z. Nagy1, K. Buga1, M. Moravszki1, G. Mikala2, T. Masszi2, I. Szilvási1
1Department of Nuclear Medicine, National Medical Center, Budapest, Hungary
2Department of Medicine, National Medical Center, Budapest, Hungary
Background: Tc-99m-sestamibi (MIBI) scintigraphy (SG) is used to study various
malignancies. Usefulness in the work-up of patients with multiple myeloma (MM)
has been recently reported.
Aim: was to asses clinical value of MIBI SG in different clinical stages of MM.
Material and methods: 70 patients with MM had whole body MIBI SG (10 minutes
after i.v. injection of 740 MBq MIBI) in the last four years, 14 of them (6 M, 8 F,
median age of 59.8 years) had multiple scans in their follow-up. 3 of the 14 patients
had monoclonal gammopathy of uncertain significance (MGUS), 3 patients were in
complete remission (CR), 6 were in partial remission (PR), 6 had incipient relapse
(IR) and 9 had clinically active stage of MM (CA). Clinical activity was determined by
serum LDH, electrophoresis, and plasma cell content of the bone marrow.
Results: All 9 scans of the 3 patients with MGUS were normal. Normal MIBI
distribution was found also in the 3 patients with CR. All patients with PR (6 cases)
or IR (6 cases) had circumscribed lesions (2 of them were extramedullary) and 7 of
them had moderately increased diffuse activity in the bone marrow. In all 9 CA
cases intensive diffuse MIBI activity in the bone marrow was found and 8 patients
had circumscribed lesions too.
Conclusions: Whole body MIBI-SG is useful to assess activity of MM in clinically
equivocal cases, and it may detect extramedullary lesions as well.
EFFECTS OF DRUGS ON THE 18FDG ACCUMULATION OF P-GLYCOPROTEIN
EXPRESSING AND NON-EXPRESSING CANCER CELLS
N. Ármós1, J.P. Szabó1, Z.T. Krasznai2, L. Balkay1, L. Trón1, N. Pótári1, T. Márián1
1Department of Nuclear Medicine, Medical and Health Science Centre,
University of Debrecen, Debrecen, Hungary
2Department of Obstetrics and Gynecology, Medical and Health Science Centre,
Debrecen, University of Debrecen, Hungary
3Institute of Nuclear Research, Debrecen, Hungary
Background: 18FDG is the most frequently used glucose analogue used in the
in vivo PET tumor-diagnostics.
Aim: To determine how cytostatic drugs, ligands used in chemotherapy modify
the accumulation of 18FDG in cancer cells expressing the MDR1 gene coding
the P-glycoprotein (Pgp) a common reason of multidrug resistance.
Material and methods: The accumulation of the 18FDG was measured in a calibrated
gamma-counter.
Results: The glucose metabolism of the Pgp expressing cell lines was significantly
higher (p < 0.05), than that of the Pgp nonexprssing counterparts. Verapamil,
(a calcium channel blocker) further increased the 18FDG accumulation of the Pgp
positive cells but did not modify the 18FDG accumulation of the Pgp negative ones.
Paclitaxel, miltefosine (cytostatics), bepridil and amilorid analogues (all Pgp
substrates or modulators), could modify the 18FDG accumulation of the cancer cells
in a Pgp dependent or Pgp independent manner. Depending on the kinds of ligands
the treatments may cause hypometabolism or hypermetabolism.
Conclusions: The masking effects of the drugs — used in chemotherapy — on the
18FDG accumulation in the tumors should be taken into consideration upon PET
diagnosis. 18FDG PET investigations, using adequate protocols may help to reveal
the multidrug resistance of tumors.
COMPARATIVE ANALYSIS OF PET AND PET/CT SCANNERS DETECTING
SMALL SIZE LESIONS WITH LOW ACCUMULATION
L. Balkay1, M. Emri1, L. Galuska1, A. Fekésházy2, Z. Lengyel3, L. Trón1
1Institute of Nuclear Medicine, University of Debrecen, Debrecen, Hungary
2PETCT Orvosi Diagnosztika Kft, Hungary
3Pozitron Diagnosztika Kft, Budapest, Hungary
Aim: To compare PET and PET/CT scanners used in the country that analyse the
detectibility of small lesions with low radioactive accumulation.
Material and methods: The Siemens Biograph 16, the GE Discovery ST and the
Siemens ECAT 47 PET scanner were tested using the lung phantom from BIODEX.
To the phantom 5 syringe of 5 mm diameter were inserted. The applied contrast
values were 8 (at 3 pieces) and 4 (at 2 pieces).
Results/Conclusions: The syringes with contrast of 8 were detectable at all PET
scanner, but the best contrast was calculated at the Siemens PETCT. The syringes
with contrast of 4 could only be visualized by the PETCT scanners. In this case the
GE scanner showed better performance in 3D mode, and it was worse using 2D
acquisition mode.
PET/CT EXAMINATIOS COMBINED WITH SENTINEL LYMPH NODE
DETECTION IN CLINICALLY N0 STAGE HEAD AND NECK SQUAMOUS
CELL CANCER
A. Fekésházy1, I. Balogh2, E. Boda2, Z. Balatoni3, K. Pócza4
1PET-CT Medical, Diagnostic Ltd., Budapest, Hungary
2Department of Nuclear Medicine, Uzsoki Hospital Budapest, Hungary
3Department of Head and Neck Surgery, Uzsoki Hospital Budapest, Hungary
4Department of Pathology, Uzsoki Hospital Budapest, Hungary
Aim: To assess the feasibility of preoperative and intraoperative sentinel lymph node
(SLN) detection combined with PET/CT in T1-3N0M0 head and neck squamous cell
cancer (HNSCC) patients. We sought the cause of the short relapse of disease
after the surgery. Was the preoperative examination appropriate? Is it true that we
know everything about the lymphatic drainage of the HNSCC?
Material and methods: We evaluated 12 (6 females, 6 males) patients with HNCC,
stages T1-3N0M0, mean age 47 (36–58). During preoperative assessment physical
examination, cervical ultrasonography (UH) and CT were performed to exclude
patients with obvious nodal metastasis. In physically, UH and CT negative cases
whole body FDG PET/CT examinations were performed for the evaluation of primary
lesion, metastatic lymphadenopathy and distant metastatic process. All patients
underwent preoperative lymphoscintigraphy and intraoperative sentinel lymph node
detection and dissection of both sentinel lymph node and PET/CT-positive lymph
node(s), followed by histopathological examination as well as immunohistochemistry.
Results: 10/12 cases PET/CT showed local metastases (no distant metastases)
but on the basis of histopathology 1/10 metastases proved to be false positive
(reactive lymph node). 2/12 patients were PET negative, but showed
micrometastases in sentinel lymph nodes. 4/10 cases were SLN negative, but the
PET discovered more than one metastatic lymph node. All but one (11/12) N0 HNSCC
cases underwent upstaging.
Conclusions: PET/CT is a very useful method in nodal staging of HNSCC patients.
Sentinel lymph node examination, starting with lymphoscintgraphy is a powerful
tool to detect nodes with only micrometastasis, undetectable with PET. Our
preliminary results show that PET/CT combined with lymphoscintigraphy and
intraoperative sentinel lymph node detection can improve the staging of HNSCC
patients.
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EARLY EVALUATION OF RESPONSE TO CHEMOTHERAPY IN PATIENTS
WITH METASTATIC COLORECTAL CANCER USING FDG PET/CT
Z. Lengyel1, Á. Petrányi2, S. Szakáll Jr.1, G. Tóth1, G. Bodoky2
1Positron-Diagnostics Ltd., Budapest, Hungary
2Saint Ladislaus Hospital, Oncology Department, Budapest, Hungary
Aim: Our aim was to assess the effectiveness of FDG PET/CT in early evaluation of
response to chemotherapy in patients with metastatic colorectal cancer.
Material and methods: Nineteen colorectal cancer patients with at least one
metastasis to the liver, as detectable by CT, were included in the study. FDG PET/
/CT was performed before and after the first cycle of therapy. Maximum of the
standardized uptake value (SUV) in the hepatic lesion was determined. At least 30%
decrease of this value as the threshold of response was chosen. The PET-response
was compared to the results of CT- and/or MR-imaging done in every two months.
Results: Considering the PET-response 10 true positive and 1 false negative results
have been documented. Among the non-responders (determined by PET) 4 true
negative and 2 false positive results have been found. Two patients have died before
the first control CT exam.
Conclusion: FDG PET/CT seems to be a suitable method for early response
monitoring in colorectal cancer.
STAGING OF HODGKIN LYMPHOMA WITH PET/18FDG IN CHILDREN
Izabela Makaiová1, Judit Puškácová2, Erzsébet Füri1, Peter Bánki1
1Clinic of Nuclear Medicine, Medical Faculty UK, St. Elizabeth Oncological
Institute, Bratislava, Slovak Republic
2University Children's Hospital, Clinic of Pediatric Oncology, Medical Faculty UK,
Bratislava, Slovak Republic
Aim: The precise initial staging and appropriate treatment of Hodgkin lymphoma
(HL) in children improve of survival. 18FDG/PET became efficient method routinely
used for staging with it’s possibility to detect this disease at metabolic level.
Material and methods: The group of investigated patients involved 41 children
with HL. At the time of diagnosis were concomitantly performed 18FDG/PET scans
and other conventional imaging methods as well. It was retrospective analysis
of staging, comparison of these all modalities performed. PET was performed with
scanner ECAT EXACT HR+ (Siemens), multimodal fusion with CT or MRI was made
with Hermes system.
Results: We analyzed 41 patients with newly diagnosed HL, 14 boys, 27 girls. In all
patients USG and CT or MRI. Concordance in these modalities was in 17/35 cases
(49%). 18FDG/PET caused upstaging in 8/35 (23%) cases. Semiquantitive estimation
was made by help of SUV (standardized uptake value).
Conclusion: Whole-body 18FDG/PET is routinely used staging method for children
with Hodgkin lymphoma. This procedure performed at the time of diagnosis
is essential for regular assessment of the treatment response.
DATA FOR THE USEFULNESS OF 3´-DEOXY-3´-[18F]FLUOROTHYMIDINE
P. Mikecz1, 2, D. Niedzielska2, O. Schulze2, R. Buchert2, W. Brenner2,
U. Kirchner2, M. Matysek2, J. Mester2
1Department of Nuclear Medicine, Medical and Health Science Centre, University
of Debrecen, Debrecen, Hungary
2Department of Nuclear Medicine, University Medical Centre Hamburg-
-Eppendorf, Hamburg, Germany
Background: 3’-Deoxy-3’-[18F]fluorothymidine (FLT) is an emerging new PET
imaging agent for visualizing cellular proliferation in vivo based on the metabolism
of thymidine. A currently published in vitro study showed, that up to ~50% of FLT is
effluxed to media, thus the studies may not give a real result about the DNA synthesis
rate.
Aim: To synthesize this popular tracer and investigate a possible role of multidrug
resistance-associated proteins on efflux of FLT and its metabolites.
Material and methods: The synthesis was performed starting from 5'-O-
Dimethoxytrityl-3'-O-nosyl-thymidine. For the in vitro experiments wild type, MRP4-
and MRP5-transfected HEK293 cells were used. HPLC analysis was applied for
the intra- and extracellular metabolite assay.
Results: Using our method FLT was reliably produced with 25% yield and 10-30
TBq/mmol specific activity. The15% of the effluxed FLT from the wild type cells was
found to be phosphorilated while in case of the MRP 4/5 transfected cells this value
was 50%. (The total efflux in both cases were over 50%).
Conclusion: Both transfected cell lines display higher efflux of phosphorilated FLT,
suggesting a possible role of MRP4- and MRP5-trasporters as a nucleotide-pump
in efflux of FLT metabolite.
CLINICAL USEFULNESS OF FDG PET/CT IN PRIMARY STAGING
PRELIMINARY RESULTS
Mónika Moravszki2, Szabolcs Szakáll1, Zsolt Lengyel1, István Szilvási2
1Pozitron Diagnosztika Kft., Budapest, Hungary
2Department of Nuclear Medicine, Semmelweis University, Budapest, Hungary
Aim: To asses clinical usefulness of FDG PET/CT in the primary staging of three
different types of malignant tumors.
Material and methods: 52 patients with diagnosed primary tumor but with equivocal
staging after clinical and radiological findings were studied. 32 patients had lung
cancer (L), 16 patients had colo-rectal cancer (CR), 4 had head and neck tumor
(HN). FDG PET examination was performed with Siemens Biograph PET/CT, after
administering 3.7 MBq/kg F-18-FDG i.v., with low dose CT protocol. The TNM stage
was determined according to the UICC TNM classification.
Results: In 37 out of 52 examinations (71%) PET/CT findings changed the originally
supposed stage. 7 cases (13%, [L: 5, CR: 1, HN: 1]) were down-staged, 30 cases
(58%, [L: 19, CR: 9, HN: 2]) were up-staged after PET/CT examination. In 15 cases
the supposed TNM stage was confirmed by PET/CT, however in 12 cases (L: 7, CR:
4, HN: 1) it revealed larger extension and/or higher number of malignant lesions
than by radiological examinations.
Conclusions: In these three types of cancer PET/CT is useful in a high percentage
of patients with equivocal clinico-radiological staging, it has a significant impact on
therapeutic management.
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SYNTHESIS AND QUALITY CONTROL OF 2-DEOXY-2-[18F]FLUORO-D-
-GLUCOSE
P. Németh1, L.Colmenter2, J. Morales2, L. Sajó-Bohus1, E.D.Greaves1, H. Barros1
1Laboratory of Radiopharmacy, Nuclear Physics Section, University of Simón
Bolívar Caracas, Venezuela
2Diagnostic Center, Caracas, Venezuela
Three years experience with the GE (9.6 MeV) Mini Trace cyclotron is given of the
synthesis and quality control of 18FDG for PET imaging. The cyclotron allows the
specific production of 29.6 GBq/h-1 of 18F with proton irradiation on a H2
18O target.
The radioisotope is transported to the TRACERLab MXFDG unit, where the synthesis
of marked deoxyglucose is carried out frommannose triflate. During this process
the trifluoromethane-sulfonate group is substituted by 18F. The sterile and pyrogen
free ABX kit, containing the necesary reagents, is employed in a computer driven
system. The whole processing time is 25 minutes. After sterilization of 18FDG quality
control is carried out by cromatography and radiocromatography analysis (HPLC,
TLC), which determines the radiochemical and radioisotopic purity including residual
chemicals (acetonitrile, ethanol, Kriptofix). The product sterility and apirogenity is
part of the analysis. Results indicate that the radionuclide purity is better than 99.5%,
and its labelling efficiency above 95%.
THE PROGNOSTIC ROLE OF 18F-FDG PET IN HODGKIN LYMPHOMA
M. Papós1, 4, I. Marton2, L. Trón3, A. Szõke2, K. Piukovics2, Z. Borbényi2,
G. Varga2, L. Pávics1
1Department of Nuclear Medicine, University of Szeged, Szeged, Hungary
22nd Department of Medicine, University of Szeged, Szeged, Hungary
3PET Center, University of Debrecen, Debrecen, Hungary
4EUROMEDIC Diagnostics Szeged Ltd, Szeged, Hungary
Aim: To investigate the diagnostic role of the 18F-FDG PET in the detection of residual
tumour in Hodgkin disease.
Material and methods: In the last decade in Hodgkin disease patients following
the primary therapy CT investigation revealed residual disease in 73 cases. 18F-
-FDG PET investigations were performed for restaging in all of these patients.
Results: 18F-FDG PET revealed active disease in 28 patients. Twenty-one of these
patients had activity sings. In 5 of the patients complete remission was found after
second-line therapy, and progressive disease was diagnosed in 16 cases. The other
7 patients did not have other activity signs, all of these patient are in stabile state.
18F-FDG PET was negative in 45 patients. In 2 of these cases recurrent disease
was diagnosed in the first year. The other 43 patients did not showed activity signs.
Conclusion: Negative 18F-FDG PET result is a good prognostic sign in Hodgkin
disease patients for the disease free survival after the first-line therapy. Positive
18F-FDG PET finding with other activity signs indicates second-line therapy. Other
investigations are required to clarify the cause of the relative high rate of 18F-FDG
positive cases, in whom second line therapy was unnecessary.
ARISING PROBLEMS DURING ONCOLOGICAL PET-CT EXAMINATIONS
V. Tóth, A. Fekésházy
PET-CT Medical, Diagnostic Ltd., Budapest, Hungary
Aim: We propose to draw attention to some relevant information which may influence
the patient preparations and exam protocols, thus evaluation of the examinations.
Material and methods: We evaluated the information included in the referral forms
in comparison with our pre examination status check of 1600 patients examined in
our centre in 2006. We were searching for the most common discrepancies and
deficiencies that may modify the previously planned examination protocol.
Results: In the referral forms, the relevant discrepancies and deficiencies were about
the location, the extent and the histological subtype (including the grade) of primary
tumor. Further important issues were the number and location of known metastases,
and potential involvement of the central nervous system, the extremities and the
urinary tract. The patient physique (weight, height), diabetes, claustrophobia, and
the time of previous treatments are also important.
Conclusions: In order to select the most appropriate examination parameters it is
essential to have certain anamnestic information. Therefore the clinician's information
should be expanded, and closer cooperation may also be established.
PET-CT EXAMINATIONS IN PREVIOUSLY TREATED ONCOLOGIC
PATIENTS WITH ELEVATED TUMOR MARKERS
Z. Tóth; A. Fekésházy
PET-CT Medical, Diagnostic Ltd., Budapest, Hungary
Aim: The purpose of this study was to assess the value of FDG PET-CT examination
in previously treated oncologic patients with elevated tumor markers, in detecting
the marker elevation's origin after the failure of conventional imaging modalities.
Materials and methods: Whole body FDG PET-CT examinations were performed
in 118 patients (51 colo-rectal, 35 breast, 12 ovarial, 8 pancreas, 4 thyroid, 4 gastric,
4 uterinal cancer patients), after unsuccessful or inconclusive previous conventional
imaging in order to detect the origin of marker elevations.
Results: With PET-CT we detected disorders suggesting primary cancer recurrence
or metastasis in 37/51 (73%) patient with colo-rectal cancer, 23/35 (60%) patients
with breast cancer, 10/12 (83%) patients with ovarial cancer, 3/8 (37,5%) patients
with pancreatic cancer, in the half (2/4) of the examined gastric, and uterinal tumor,
and quarter (1/4) of thyroid cancer cases.
Conclusion: FDG PET-CT examination seems to be an accurate technique in early
detection of disease recurrence in previously treated oncologic patients with elevated
tumor markers.
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NEUROLOGY AND PSYCHIATRY
THE DOPAMIN TRANSPORTER ACTIVITY IN DEPRESSION
AND THE EFFECT OF SERTRALINE TREATMENT
Z. Besenyi1, 2, M. Árgyelán1, 3, Z. Szabó3, S. Kéri3, Z. Janka3, L. Pávics1, 2
1Euromedic Diagnostics Szeged Ltd., Hungary
2Department of Nuclear Medicine, University of Szeged, Szeged, Hungary
3Department of Psychiatry University of Szeged, Szeged, Hungary
Aim: To evaluate the DAT activity of untreated patients with depression compared
to healthy volunteers. We also studied the effect of sertraline on DAT activity in
depression.
Material and methods: We performed overall 18 123I-FP-CIT SPECT examinations
in 6 healthy volunteers and 6 depressed patients. In age-matched healthy subjects
and in patients baseline investigations were performed in depressed patients the
SPECT investigation was repeated after 3 weeks sertraline treatment. Striatal volume
of interest were fixed by automatic technique. The binding potential (BP) was
estimated by the ratio of the specific to non-specific activity.
Results: In the patients group, the median baseline BP was 3.35, in the control
group, this value was 3.58, difference was not statistically significant (Z = –0.32,
p = 0.74). In the patient group, the median BP after sertraline administration was
2.98, which indicates a decrease of 11.0% of FP-CIT binding however, this alteration
statistically was not significant.
Conclusion: We didn't find any significant difference in the baseline values of DAT
activity between control and untreated depressed subjects. Sertraline treatment
decreased the DAT occupancy (11%).
SPATIAL STANDARDISATION OF RCBF-SPECT IN EARLY DEMENTIA
PATIENTS AND HEALTHY CONTROL SUBJECTS
T. Györke1, P. Barsi2, 4, T. Kovács3, I. Gyuricza1, B. Kári1, K. Karlinger1, G. Balázs4,
G. Opposits5, L. Trón5, M. Emri5
1Department of Diagnostic Radiology and Oncotherapy, Faculty of Medicine,
Semmelweis University, Budapest, Hungary
2MR Research Centre, Semmelweis University, Budapest, Hungary
3Department of Neurology, Faculty of Medicine, Semmelweis University,
Budapest, Hungary
4Department of Cardiovascular Surgery, Faculty of Medicine, Semmelweis
University, Budapest, Hungary
5Institute of Nuclear Medicine, University of Debrecen, Debrecen, Hungary
Aim: In order to perform population level statistical analysis (SPM) of rcbf-SPECT
in early dementia we investigated the reliability of spatial standardisation (SS).
Material and methods: SPECT and T1 weighted MRI investigations of 15 patients
with early dementia and 11 healthy subjects were used. SS based on MRI and
based only on SPECT data were compared using the statistical comparisons of the
perfusion distributions measured in the same location of the brain. These areas
were delineated in healthy regions with digital brain atlas software. For registration
free of charge or commercially available and own developed softwares were applied.
Results: We have shown that the MR based SS is more accurate than the SPECT
based one. However the SPECT based SS offers good input for the population level
SPM analysis. In the case of severely hypo-perfused areas the MRI images are
indispensable.
Conclusion: With the above limitations SPECT based SS proved to be reliable
enough in this study population for the population level SPM analysis.
CLINICAL EXPERIENCES WITH X-RING/4R DEDICATED BRAIN SPECT
SYSTEM
T. Györke1, L. Nagy2, A. Farkas2, J. Turák2, J. Östör2, K. Karlinger1, B. Kári1
1Department of Diagnostic Radiology and Oncotherapy, Faculty of Medicine,
Semmelweis University, Budapest, Hungary
2MEDISO Ltd., Budapest, Hungary
Aim: To demonstrate our clinical experience with X-Ring/4R four-head brain SPECT
system (XR4R).
Material and methods: NaI(Tl) based detectors of XR4R offer high intrinsic resolution
(< 2.3 mm in 230 * 220 mm UFOV). LEHR/UHR collimator sets are available. 2 mm
isotropic voxel-size is used for both phantom and clinical studies. 123 rcbf patient
studies using 99mTc-ECD/HMPAO were performed and evaluated by InterViewXP™.
52 volunteers have been acquired by both dual-head camera (ADAC) and XR4R.
Iowa 3D Brain Phantom has been used also for brain structure recognition.
Results: XR4R produced morphologically highly detailed images reflecting the brain
anatomy. In clinical routine the high resolution images had great impact in the
diagnosis of functional abnormalities in deep brain structures. The optimum
performances are provided by LEHR collimator set with ~25 min. acquisition time.
Conclusion: XR4R offers anatomically detailed high resolution functional images of
the brain improving the diagnostic evaluation of rcbf SPECT studies.
OUR FIRST EXPERIENCE WITH I-123-FP-CIT SPECT IN PATIENTS
WITH PARKINSONISM
E. Takács1, Z. Széplaki2, A. Radácsi1, K. Soós2, R. Szegedi2, I. Szilvási1
1Department of Nuclear Medicine, Kútvölgyi Clinical Center, Semmelweis
University, Budapest, Hungary
2Department of Neurology, Kútvölgyi Clinical Center, Semmelweis University,
Budapest, Hungary
Aim: To evaluate clinical usefulness of I-123-FP-CIT SPECT in patients with
Parkinson's disease (PD).
Material and methods: Striatal dopamine transporter density was studied in 12
patients. 9 of them had PD and 3 had tremor from other neurological disorders.
Three hours after i.v. injection of 185 MBq I-123-FP-CIT SPECT was performed.
Transaxial images of the brain were evaluated semiquantitatively. Binding ratio (BR)
of the striatum to the occipital cortex were calculated by using operator independent
volume of interest. Clinical stage was evaluated by standard neurological (Hoen-
-Yahr and Webster) criteria.
Results: Mean striatal BR of patients with PD (2.1 + 0.12) was significantly lower
than in patients with other neurological disorders mimicking parkinsonism (3.15 +
+ 0.11). Clinical condition of patients correlated with BR values. Patients with severe
parkinsonism had lower BR values.
Conclusions: Our first experience indicate that I-12-FP-CIT SPECT seems to be a
useful tool in differential diagnosis of clinically equivocal cases with suspected PD
and it may provide an objective method of monitoring the clinical condition of patients.
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KIDNEY
TARGETED RADIOTHERAPY OF BRAIN TUMORS
Michael R. Zalutsky
Departments of Radiology and Biomedical Engineering, Duke University Medical
Center, Durham, United States
External beam radiation therapy is rarely curative for gliomas and other central
nervous system malignancies due to its lack of tumor specificity. Moreover, external
beam radiation generally results in damage to adjacent normal tissues,
compromising neurologic function and quality of life in the few patients who do
survive. Targeted radiotherapy is an attractive alternative treatment strategy that
utilizes a molecular vehicle such as a monoclonal antibody (mAb) to selectively
deliver radionuclides to tumour cells.  We have been evaluating the potential utility
of radiolabeled mAbs specifically reactive with the extracellular matrix glycoprotein
tenascin, which is over expressed in more than 95% of high grade glioma.  A series
of Phase I and Phase II clinical trials have been performed in both recurrent and
newly diagnosed brain tumour patients with the murine and human/mouse chimeric
forms of anti-tenascin mAb 81C6 and labeled with 131I. In all cases, the labeled mAb
was injected via a surgically created brain tumor resection cavity (SCRC);
pharmacokinetics, dosimetry, toxicity and prolongation in median survival were
assessed. Because of regulatory issues, these trials were done on an administered
activity basis, resulting in a wide range of radiation doses to the SCRC due to
variations in SCRC volume and biokinetics among the patients. Nonetheless,
encouraging prolongation in median survival were observed. Our most recent trial
in newly diagnosed patients was designed to deliver an average dose of 44 Gy to
the 2-cm SCRC margin based on dosimetry calculated from serial imaging. Median
overall survival for all patients and those with glioblastoma multiforme (GBM) was
96.6 and 90.6 weeks, respectively, longer than any other therapeutic approach
described in the literature. Radionuclides that emit a-particles such as 7.2-h half-life
211At (astatine) offer the possibility of combining cell-specific molecular targeting
with radiation having range of only a few cell diameters. Furthermore, a-particles
are considerably more cytotoxic that conventional radiation and their effectiveness
is independent of dose rate and oxygen. We have just completed a Phase I trial
evaluating 211At-labeled chimeric 81C6 mAb administered into SCRC in recurrent
glioma patients. Astatine-211 was produced at the Duke University Medical Center
cyclotron and mAb 81C6 was labeled with preservation of immunoreactivity using
N-succinimidyl 3-[211At]astatobenzoate. Eighteen patients including 14 with GBM
received 10 mg of mAb labeled with escalating activities (74–370 MBq) of 211At.
Retention of activity in the resection cavity was excellent with less than 0.5% of the
injected dose found in the blood pool. Median survival in these recurrent GBM and
non-GBM brain tumour patients was 52 and 97 weeks, respectively, and 3 patients
including 2 with GBM survived for 3 years. We are currently performing preclinical
studies to evaluate the potential of other 211At-labeled compounds for the targeted
radiotherapy of brain tumours.
USE OF CORN OIL EMULSION AS A TEST MEAL IN BILIARY SCINTIGRAPHY
I. Földes, D. Nagy
Department of Nuclear Medicine, BM. Hospital, Budapest, Hungary
Aim: Corn oil has been recently proposed as a stimulant to improve
cholescintigraphy. We thought to compare the effect of milk, a test meal, used for
several years in our department, to corn oil.
Material and methods: 37 subjects (30 female and 7 male) were enrolled in “corn
oil group”. Nineteen patients had intact gallbladder and 18 patients were formerly
cholecystectomized. The “milk group” had 42 members: 21 with gallbladder and 21
cholecystectomized patients. Biliary scintigraphy was performed by injecting 100
MBq 99mTc-Techida i.v. We used test meals of 250 ml milk or 30 ml corn oil
suspension. In patients with gallbladder, the stimulation was performed at the moment
of peak filling whereas in the cholecystectomized group, 10–15 minutes after reaching
the maximum of common bile duct time-activity curve. The gallbladder ejection rate
has been characterized by the half time (T1/2) of the initial fast ejection period. In
patients without gallbladder, T1/2 of the descending slope of common bile duct curve
was evaluated before and after the test meal.
Results: 14 patients showed gallbladder contraction and 5 patients revealed no
effect in response to corn oil ingestion. The initial fast ejection period lasted for
19.4± 2.5 (mean ± SE) minutes, T1/2 was 30.1 ± 5.3 minutes. After milk
administration, the gallbladder started to contract in 19 patients, whereas two showed
no reaction. The fast ejection lasted for 18.7 ± 1.2 min, and the T1/2 was 40.2 ± 4.6
min. The mean of “corn oil” and “milk” population did not differ significantly
(P = 0.16). In patients without gallbladder, corn oil increased the rate of biliary flow
into the duodenum in 8 cases, T1/2 was 32.4 ± 3.5 min before eating, and 20.2 ± 2.2
min after stimulation. The biliary flow remained unchanged in 9 subjects, and became
much slower in one. Administering milk, the rate of the biliary flow was accelerated
in 10 patients having no gallbladder, T1/2 was 30.7 ± 4.5 min. before eating and
decreased to 13.2 ± 1.5 min after milk. In 10 patients, no changes have been
observed or even had no flow in one case. In cholecystectomized patients, milk-
induced bile flow was more potent compared to that of corn oil (P < 0.05).
Conclusion: We have shown that corn oil is effective as a test meal. Although we
have proven that it is not stronger than milk, yet it can be better standardized. Having
no side effects, corn oil may be convenient for patients with lactose intolerance.
GASTROINTESTINAL TRACT
EVALUATION OF THE RELATIONSHIP OF METABOLIC STATUS
WITH GASTRIC EMPTYING AND DIABETIC NEUROPATHY
M. Papós1, 2, T. Várkonyi3, É. Börcsök3, R. Takács3, C. Lengyel3, M. Lázár1, 2,
P. Kempler4, E. Máté5, J. Lonovics3, L. Pávics1
1Department of Nuclear Medicine, University of Szeged, Szeged, Hungary
2EUROMEDIC Diagnostics Szeged Ltd, Hungary
31st Department of Medicine, University of Szeged, Szeged, Hungary
41st Department of Medicine, Semmelweis Universtiy Budapest, Hungary
5Institute of Informatics, University of Szeged, Szeged, Hungary
Aim: To investigate the relationship with the actual glucose level, with gastric emptying
and the neuropathy in 13 patients with type-1 diabetes (DM).
Material and methods: The emptying of the stomach was evaluated by scintigraphic
method. The subcutaneous glucose levels were monitored continuously during the
investigation. Cardiovascular reflex tests were applied for the assessment of
autonomic neuropathy (AN). Sensory nerve integrity was studied with electric
stimulation.
Results: The gastric emptying in diabetic patients was delayed (T1/2: 84.4  ± 12.4
vs. 49.6 ± 5.5 min., p = 0.06). The glucose levels recorded during the gastric
emptying (the lowest and highest, the mean, the highest difference) did not correlate
with the gastric motility. Moderately severe AN was found in diabetics (AN score:
2.9 ± 0.5 vs. 0.3 ±  0.2, p < 0.001). The current perception thresholds on the
peroneal nerve of the patients differed from controls (3.12 ± 0.9 vs. 0.68 ± 0.07 mA,
p < 0.05).
Conclusions: Slightly slower gastric emptying was found in the presence of
a moderately severe autonomic and sensory neuropathy in DM. The actual glucose
level plays a less important role than neuropathy in the pathogenesis of delayed
gastric emptying.
THE ROLE OF STATIC RENAL SCINTIGRAPHY FOR THE DETERMINATION
OF SPLIT RENAL FUNCTION IN CASE OF PEDIATRIC UROPATHIES
REQUIREING SURGERY
É. Horváth, J. Miklósi, M. Turopoli, A. Képes, E. Gergely
Department of Diagnostic Radiology and Oncotherapy, Faculty of Medicine,
Semmelweis University, Budapest, Hungary
Aim: Dynamic renal scintigraphy (MAG3) has an important role in the diagnostic
workup of pediatric obstructive uropathies (OU) and vesicoureteric reflux (VUR).
Frequently surgery is indicated for the correction of anatomic abnormality or in case
of severely damaged renal function (SDF) for nephrectomy. We investigated the
role of complementary preoperative static renal scintigraphy (DMSA) performed for
the determination of split renal function (SRF).
Material and methods: We compared SRFs calculated on the base of MAG3 and
DMSA performed within one month in 40 pediatric patients (age: 1 m.–16 y.; 6 OU,
34 VUR).
Results: The difference between the percentage functions of an individual kidney
calculated from DMSA and MAG3 was 0–8%.
Conclusion: DMSA based SRF has no clinically relevant added value if the functional
state of the kidneys is relatively preserved. In case of SDF MAG3 tends to overestimate
the function of diseased kidney due to higher background activity Consequently
DMSA may verify the reasonebless of nephrectomy.
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COMPARISON OF PROCEDURES FOR MEASURING RENAL CLEARENCE
Margit Paál1, Orsolya Jászberényi2, Gábor Zakar3
1Department of Isotope Laboratory, Szent György Hospital of Fejér County,
Székesfehérvár, Hungary
2Multilab-Diagnosztika Ltd., Székesfehérvár, Hungary
31st Department of Internal Medicine, Szent György Hospital of Fejér County,
Székesfehérvár, Hungary
Aim: The aim of this work was to compare the well-known methods suitable for
measuring renal clearence — from both chemical-laboratory and isotopic aspects,
and to examine their authenticity.
Material and methods: At first, chemical-laboratory methods were carried out, the
renal clearance was measured by using cystain. Two types of blood samples were
collected: (i) the test tube contained coagulation accelerator, (ii) it was free of such
an agent. In the isotopic examinations 99mTc-DTPA was used as radiopharmaceutical,
both camera clearance and bloodtest clearance were determined.
Results: Our results are very variable. The divergences between the two chemical
examinations are slight, proving obviously that there is no difference in the analysis
of blood samples taken in the two types of tubes. The coagulation accelerator crystals
do not influence the results of the test, however, compared to the test results of the
isotopic blood samples, the divergences concerning the individual patients are large.
Camera clearance data are absolutely unreliable, they depend very much on the
manner of placing ROI-s around the kidneys.
Conclusion: The camera clearance should not be recommended to measure renal
clearance.
BASIC SCIENCES
CHAPTERS FROM THE PREPARING SPECT/CT ATLAS
L. Balogh1, G. Andócs1, D. Máthé1, A. Polyák1, P.R. Chaudhari2, T. Das2, R. Király1,
J. Thuróczy3, N. Oppe3, G.A. Jánoki1
1Department of Applied Radioisotopes, National “F.J.C.” Research Institute
for Radiobiology and Radiohygiene, Budapest, Hungary
2Bhabha Atomic Energy Institute, Mumbay, India
3Veterinary Faculty, Szt István University, Budapest, Hungary
Aim: We goaled to edit a nano SPECT/CT atlas describing the normal radiophar-
maceutical biodistributions in healthy rodents for assisting the radiopharmaceutical
research and development and companying biomedical research. The atlas will be
published in hard copy and CD versions.
Material and methods: A nano SPECT/CT instrument developed by Mediso Ltd
was used. All the examinations were carried-out in living, anaesthetized (isoflurane)
rats and mice. All the most conventional 99mTc labeled radiopharmaceuticals
t (99mTc-pertechnetate, 99mTc MDP, 99mTc MIBI, 99mTc HM-PAO, 99mTc HSA, 99mTc-
colloids, 99mTc-IgGs) and some177Lu and 186Re-labelled ligands were injected iv, then
whole-body CT and nuclear medicine imaging was carried-out. After reconstructur-
ing the CT, NM and fusion pictures visual and some detailed quantitative examina-
tions (kidney, liver, thyroid … uptake) were done.
Results: We worked-out the examination protocols for the preparing atlas in healthy
mice and rats by injecting the most important 99mTc-labelled radiopharmaceuticals.
The whole-body CT, nuclear medicine and fusion images have been edited in
a printed and CD form.
Conclusion: The nanoSPECT/CT (Mediso Ltd) instrument used by us proved to be
applicable for dataful, high-resolution CT, NM and fusion imaging of laboratory
animals. Radiotracer uptake by different organs calculated on an image-based way
showed high correlation with conventional standard bioassay data.
POSTVACCINATION AMYLOIDOSES IN GEESE — A SPONTANEOUS ANIMAL
MODEL FOR RADIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT
L. Balogh1, B. Kovács2, P. Rudas2, J. Thuróczy2, D. Máthé1, A. Polyák1,
P.R. Chaudhari3, T. Das3, G.A. Jánoki1, L. Kõrösi1, R. Király1
1Department of Applied Radioisotopes, National “F.J.C.” Research Institute
for Radiobiology and Radiohygiene, Budapest, Hungary
2Veterinary Faculty, Szt István University, Budapest, Hungary
3Bhabha Atomic Energy Institute, Mumbay, India
Aim: Amyloid detection is a great challenge for the clinicians so developing new
amyloid targeting agents is an ever rising problem in radiopharmaceutical research.
The aim of this work was to study the availability of the better known 99mTc-DMSA(V)
and an in-house produced 99mTc labelled anti serum amyloid-A (anti-SAA IgG)
in amyloid detection in geese.
Material and methods: Altogether 16 geese (4 healthy, 12 postvaccination
amyloidoses) was selected for scintigraphycal examination. Birds were sedated
(ketamin-HCl, iv), catheterized in both saphenic veines, then injected with either
400 MBq 99mTc-DMSA(V) (Penta DMSA®, Medi-Radiopharma, Hungary) or with
99mTc-anti-SAA IgG (400 MBq/1 mg IgG). Dynamic scans between 0–30 minutes
from ventral view, than static whole-body pictures from ventral and left lateral side
were taken 30 minutes, 1, 2, 4, 6, and 24 hours after application. Geese were
euthanized; heart, lungs, spleen, liver, kidneys, testes (or ovaries), and the whole
GI-tract were removed and provided for ex vivo scintiscans. Samples from all the
listed organs were sent for histopathological examination (HE and IH) for checking
the presence of amyloid deposits. Scans were evaluated visually, residency times
and internal dosimetrical data (OLINDA) were estimated and compared.
Results: Both radiopharmaceuticals failed to detect the very mild (+/– and + positive
IH) amyloidosis in the organs. Only ++ and +++ positive organs could be detected.
99mTc-DMSA(V) is available for in vivo visualising the amyloid deposits in the lungs,
heart, and intestines, while in the 24 hours ex vivo scans the spleen, liver and testis
(ovaries) as well. Similarly, in the in vivo 99mTc-anti-SAA scans the lungs, heart,
and intestines were visualised, but in the ex vivo scan spleen, liver, reproductive
organs, parts of GI-tract and kidneys showed higher accumulation in diseased
animals. Organs containing ++ or +++ amyloid deposits (IH) showed significantly
higher mean residency times (20–80%) than healthy bird's organs.
Conclusion: Both 99mTc-DMSA(V) and 99mTc-anti-SAA IgG proved to be available for
detecting amyloid deposits however doe to the not focal but systemic disease
amyloid detection in the excretory organs is often difficult. Postvaccination geese
found to be an ideal animal model for amyloid research.
PREPARATION OF 99M TC LABELLED LIPOSOMES AND LIPOPROTEIN
MACROMOLECULES FOR THE SCINTIGRAPHIC DETECTION
OF THE PLAQES OF ATHEROSCLEROSIS AND TUMOR CELLS
Zoltán Bozóky, Lajos Balogh, Domokos Máthé, Gyõzõ Jánoki
Department of Applied Radioisotopes, National “F.J.C.” Research Institute
for Radiobiology and Radiohygiene, Budapest, Hungary
Background: We have prepared radiolabelled lipoproteins and liposomes for the
scintigraphic detection of experimental atherosclerotic lesions and tumor cells in
animal models.
Material and methods: We have isolated Low Density Lipoproteins (LDL) by
preparative ultracentrifugation. Liposomes were obtained from fragments of
lipoproteins and from phospholipids and cholesterol with similar features to
lipoproteins. Radiolabelling of lipoproteins and liposomes with 99mTc were
performed using sodium dithionite as a reducing agent. Radiochemical purity and
in vitro stability of radiolabelled components were controlled by paper
chromatography. Rabbits fed a diet containing 1% cholesterol for 60 days.
Implantation of human tumor cells were made in nude mice. Gamma scintillation
camera imaging of the rabbits and mice were performed for radiolabelled lipoproteins,
and liposomes.
Results: The analytical and preparative ultracentrifugation methods proved to be
useful to obtain and control lipoprotein aliquots for radiolabeling. Labeling efficiencies
were more than -90% for lipoproteins and liposomes. Mean uptake of 99m Tc-labelled
lipoproteins and liposomes in the aorta (mainly in aorta arch) and in carotid arteries
were higher in hypercholesterolemic rabbits than in normal rabbit controls (about
3 fold quantity increased uptake in targets), which were confirmed by pathological
examinations. In nude mice developed human tumor cells were detected compare
with controls animals with radiolabelled LDL and liposomes.
Conclusions: Our preliminary results showed that in vivo scintigraphy revealed visible
signal corresponding to atherosclerotic plaques and tumor cells by radiolabelled
lipoprotens and liposomes. Liposomes can be made from lipids which closely mimic
the metabolic behaviour and receptor binding features of lipoproteins and they have
got importance in examinations.
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PREPARATION AND BIODISTRIBUTION OF 99MTECHNETIUM LABELLED
CEFTIOFUR: A POTENTIAL INFECTION IMAGING AGENT
P. Chaudhari1, B. Kar1, M. Gatne2, M. Devare2, V. Khare3, L. Balogh4, G. Janoki4,
M.G.R. Rajan1
1Laboratory Nuclear Medicine Section, Bhabha Atomic Research Centre,
Tata Memorial Annexe, Mumbai, India
2Department of Pharmacology, Bombay Veterinary College, Mumbai, India
3Extol Institute of Life Science, Barkatullah University, Bhopal
4National "F.J.C." Research Institute for Radiobiology and Radiohygiene,
Budapest, Hungary
Aim: To establish a labeling protocol and evaluate biokinetics of the 99mTc-Ceftiofur.
Material and methods: Labeling of Ceftiofur with 99mTc was carried out as follows:
5.0 ± 0.5 mg Ceftiofur dissolved in 80 ml of 2 M NaOH solution, 300 mg SnCl2 and
99mTcO4- (~10 mCi in 0.2 ml saline) in a final reaction volume of 1ml made up with
distilled water. The pH of the final solution was adjusted to 6–7 using 1 M NaH2PO
solution. The 99mTc-Ceftiofur was injected into normal, healthy animals through the
tail vein for biodistribution studies. Imaging studies were carried out in normal rabbit,
the images were acquired at 1, 3, and 24 h p.i. using 256 x 256 matrix size with
LEHR collimator (GE Infinia system, SPECT-CT Unit, Bio-Imaging Facility, Tata
Memorial Centre).
Results: The radiochemical purity (RCP) of 99mTc-Ceftiofur was > 90%. The in vitro
stability of the complex was confirmed by carrying out RCP check over period of
4 hours. The circulating levels were a maximum (7%) at 30 min and, thereafter,
decreased to 0.8% at 24 h. The liver uptake was also maximum (9.8%) at 30 min
and decreased to 2.1% at 24 h. The muscle uptake was maximum (0.8%) at 30 min.
Bone uptake was found to be very negligible at all time points. Excretion of the
compound was both through the renal system and hepatobiliary route. Renal uptake
was observed ~20 to 24% at all time points.
Conclusion: The labeling protocol of 99mTc-Ceftiofur was established and the
radiochemical purity of the complex was > 90%. The prolonged presence of drug in
circulation will be an added advantage for infection imaging particularly for lesions
in thorax, which needs to be evaluated in animal models of infection.
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NUCLEAR MEDICINE IMAGING: A TOOL FOR REDUCING NUMBER
OF LABORATORY ANIMALS REQUIRED FOR BIO-MEDICAL RESEARCH
P. Chaudhari1, L. Balogh2, D. Mathe2, G. Janoki2, M.G.R. Rajan1, T. Das3,
M. Venkatesh3
1Laboratory Nuclear Medicine Section, Bhabha Atomic Research Centre, Tata
Memorial Annexe, Mumbai, India
2National “F.J.C.” Research Institute for Radiobiology and Radiohygiene,
Budapest, Hungary
3Radiopharmaceuticals Division, Bhabha Atomic Research Center, TMC Annexe,
Mumbai, India
The animal experimentations are going through a transformation phase, with more
emphasis on 3R (Refinement, Reduction and Replacement) principles laid down by
Russell and Burch. Radioisotopic techniques has potential to reduce the number of
laboratory animal in bio-medical research. Radioisotopes are commonly used as
tracers in bio-medical research and known for quantative precision. It has wide
applicability in studying different physiological and biochemical mechanisms in
various organs. Nuclear imaging or scintigraphy is a simple, non invasive procedure
involving the administration of a molecule or compound of interest labeled with
gamma emitting radioisotope and subsequently, mapping the distribution of the
radioisotope in vivo using a gamma camera.
The preclinical evaluations of radiopharmaceuticals require animal studies and the
primary screening is performed in small rodents. These biodistribution studies are
carried out to measure the localization of newer radiopharmaceutical in various
organs with a function of time. These studies are invariable replaced by in vivo
scintigraphy imaging using dedicated systems for animal imaging. The images
obtained are indicative of distribution of the radiolabeled compound in the animal
body. These images can be acquired at various time-interval without sacrificing the
animals. The same animal can be studied over a length of time, which also minimizes
experimental variation.
We have performed scintigraphic studies in rat, mice rabbits, dogs using rat, mice
rabbits, dogs using various SPECT and PET radiopharmaceuticals such as
177Lu-EDTMP, 99mTc-Cefteofur, 18Fluroride, 131Iodine labeled with a virus compliment
protein. The various studies carried out are discussed in depth with emphasis on
impact of scintigraphy in reducing dissections of the laboratory animals. These
studies have reduced the number of biodistribution studies and ultimately the number
of animals, and provided precise functional information about the new ligands. The
dynamic and static high-resolution images were obtained with advanced animal
imaging system nanoSPECT.
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THE NA+/I– SYMPORTER (NIS), AS A PARADIGM FOR TRANSLATIONAL
RESEARCH: “TRANSPORTING” KNOWLEDGE FROM THE BEDSIDE
TO THE BENCH AND VICE VERSA
O. Dohán1, 2, N. Carrasco1
1Albert Einstein College of Medicine, New York, United States
2Szent Rókus Kórház és MTA KOKI, Budapest, Hungary
The Na+/I– symporter (NIS), mediates active I– uptake for thyroid hormone
biosynthesis and radioiodide transport for diagnosis and treatment in thyroid cancer.
We investigated the decrease in I– transport in thyroid cancer. We have reported
that in the majority of thyroid cancers, NIS is surprisingly overexpressed as compared
to the surrounding tissue but retained intracellularly. We also demonstrated that the
NIS carboxy terminus contains crucial information for NIS polarized plasma
membrane targeting.
TSH and I– are the two main factors that regulate thyroidal I– transport. Strikingly we
found that the downregulation of I– transport by I– is thyroid-specific, TSH-independent
and mediated by a redox mechanism resulting in NIS oligomerization.
One of the most exciting area of NIS research — radioiodide treatment of
extrathyroidal cancers — opened when endogenous, functional NIS expression was
described in breast carcinoma, and the NIS cDNA was introduced into non NIS
expressing tumors. Our results indicate that NIS-transported radioiodide appears
to be a highly promising novel approach to achieve the targeted therapeutic
destruction of mammary adenocarcinomas and their metastases.
QUANTIFICATION OF ISOTOPE UPTAKE IN THE MOUSE THYROID
USING THE NANOSPECT/CT® SMALL ANIMAL IMAGER
I. Földes1, D. Máthé2, L. Balogh2, G.A. Jánoki2
1BM Central Hospital, Budapest, Hungary
2Department of Appied Radioisotopes, ational Frédéric Joliot-Curie Institute
of Radiobiology and Radiohygiene, Budapest, Hungary
Aim: Production of quantitative, calibrated in vivo data on the isotope uptake of
healthy mouse thyroids using 99mTc-pertechnetate and 131I with SPECT.
Material and methods: To date, Bioscan/Mediso NanoSPECT/CT is the only small
animal imager proven to be capable of exact quatification of organ activity uptake
with SPECT. Phantoms containing a known activity were prepared (0.1–0.3 MBq
99mTc or MBq 131I per thyroid model). SPECT/CT scans were made of the phantoms.
Activity in the phantoms was determined using the Voxel of Interest (VOI) technique
with the dedicated software Mediso  InterView XP. Following phantom measurements,
3 mice were injected with different activities (8–30 MBq) of 99mTcO4 solution and
SPECT/CT scans were made.  Activity in thyroid and salivary glands was determined
using VOI technique. Animals were then killed and activity in thyroids and salivary
glands was determined in a well-type gama counter.
Results: Voxel of Interest (VOI) measurements on the 99mTc isotope phantoms equal
measured values of precalibrated activity with two digits exactness if the scans
contain over 3 000 000 of total counts. Duration of SPECT/CT scans remained below
20 minutes. VOI-determined activities of mouse organs were identical of those
measured in well-type gamma counter with a mean difference of 5%. Good quality
images were obtained using 131I as well even with activities below 0.1 MBq. Due to
low activities duration of 131I imaging was over 3 hours.
Conclusions: Exact absolute quantification of 99mTcO4 isotope uptake of mouse
thyroids is possible using the Mediso-Bioscan NanoSPECT/CT imager with a
submillimeter resolution also using iodine 131 isotope. This leads to new possibilities
in thyroid imaging and therapy research.
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PRECLINICAL EVALUATION OF 177LU-LABELLED RADIOPHARMACEUTICALS:
177LU-EDTMP
G.A. Jánoki, L. Balogh, D. Máthé, A. Polyák, L. Kõrösi, R. Király
Department of Applied Radioisotopes, National “F.J.C.” Research Institute
for Radiobiology and Radiohygiene, Budapest, Hungary
177Lu-EDTMP prepared in our laboratory was tested on four animal species in order
to obtain relevant preclinical data on biodistribution, pharmacokinetic, dosimetry
and possible side effects may occurring when compounds used for palliation in
high activity dose (≥ 37 MBq/Kg bodyweight).
In a labelling experiment 2–2.2 GBq 177LuCl3 in final volume of 5 ml was used.
After 30 minutes of incubation radiochemical purity reached  > 95%.
In mice and rats standard biodistribution and nano SPECT/CT was used. In rabbits
and dog to follow biodistribution and excretion gamma camera (Nuclide-X-Ring,
Mediso) was applied. With blood and urine sampling and with organs ROI technique
pharmacokinetic data collection were done. Images taken up to 5 weeks supported
biodistribution studies.
All animals showed fast blood clearance (MRT: 2.83 hrs) and high rate of kidney
excretion (AUC = 29.2% h/g) after 2 hrs of i.v. injection. Bone uptake ranged
25–45% of I.D. and remained skeleton bound even after 5 weeks (MRT: 639 hrs).
Scintigraphic image after 2–3 hours showed skeletal localization only Digital
autoradiography in mice and rats has proven the binding to cortical bone.
A radiotoxicological investigation of blood counts and different biochemical
parameters showed moderate platelets decrease. Favorable pharmacokinetics and
dosimetric evaluation based on residence time determination showed high normal
bone absorbed dose with moderate bone morrow and kidneys dose.
177Lu-EDTMP in all experiment showed fast excretion and high skeletal uptake.
The moderate side effects occurring at a high activity dose predict a very efficient
palliative application in human.
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SYNTHESIS OF THE 9-(4-[18F]-FLUORO-3-HYDROXYMETHYLBUTYL) GUANINE,
A RADIOTRACER FOR REPORTER GENE PROBES
István Kertész1, Mariann Gyöngyösi2, Jeronimo Blanco3, László Balkay1,
Örs Petneházy4, Zsolt Petrási4, Pál Mikecz1, László Galuska1, Lajos Trón1,
Teréz Márián1
1Institute of Nuclear Medicine, Medical & Health Science Centre, University of
Debrecen, Hungary
2Department Cardiology, University of Vienna, Austria
3Centro de Investigation y Desarrollo (CSIC), Barcelona, Spain
4University of Kaposvár, Hungary
Cardiovascular disease remains a leading cause of death in the Western world.
Recently, successful myocardial regeneration from stem cell differentiation has
reported in animal studies. Subsequent human clinical trials have shown improved
myocardial contractile function and perfusion after stem cell injection in patients
with acute myocardial infarctions.
The reporter gene expression image study may be a powerful method for visualization
of the success of the stem cell transplantation. We have synthesised the 9-(4-[18F]-
-Fluoro-3-Hydroxymethylbutyl) Guanine ([18F]FHBG), which is reported to be potent
against HSV types 1. The precursor was labelled by a conventional nucleophile
substitution. The intermediate was purified by SPE. The protecting groups are
removable by acidic hydrolysis. The final purification was performed by RP-HPLC
followed by a sterile filtration. The radiotracer was tested in vitro and in vivo.
Our results in the in vitro pig steam cell experiments showed a significant
accumulation of the [18F]FHBG in the HSV1 gene expressing cells compared with
the control ones, while in the in vivo experiments the stem cells injected heart of the
pigs showed remarkable specific [18F]FHBG activity.
PRECEDENTS AND OUTLOOKS OF NUCLEAR MEDICINE IN HUNGARY
László Kertész
Nuclear Medicine adviser in pens., organizer of the MONT
One must clearly see whether our profession can be fulfilled by true sense of vocation
after having managed its acceptance a lifetime ago; the literary statement being
valid also here “the greatness of a vocation stands in unifying people...”. Due to
a country-wide sampling last year, we can point out that this professional commitment
should be two-directional. On the one hand we have to appreciate the positive,
successful activity of our colleagues which needs even more selfrestraint in the
present time scramble. On the other hand we must not overlook the “tracer principle”
to be asserted in choosing of our work and to interpret the results — surely this
being our greatest asset. Here, we may consider such possibilities like the
manifestation about “dissection of the consciousness with PET” intended recently
by an ATOMKI-generated Hungaro-Swedish team, also new instances of fusional
nano-imaging which parallel on an advanced level with our very first efforts in the
post-war years.
TESTING AND VALIDATING OF A PARALLEL IMAGE RECONSTRUCTION
SOFTWARE PACKAGE
S.A. Kis1, L. Trón1, G. Opposits1, P. Veres1, Á. Pányik1, Gy. Kovács1, L. Balkay1,
L. Pohubi2, Á. Szlávecz3, J. Molnár4, L. Galuska1, M. Emri1
1University of Debrecen Institute of Nuclear Medicine, Debrecen, Hungary
2MEDISO Ltd., Budapest, Hungary
3BME, Department of Information Technology, Budapest, Hungary
4Institute of Nuclear Research of the Hungarian Academy of Sciences, Debrecen,
Hungary
Aim: Our institute as a consortium member plans to build a demonstration version
of a full ring small animal PET scanner. The software system attending this device
has to accommodate full 3D- and conventional 2D reconstruction algorithms.
For the huge calculation and storing capacity required by 3D methods demand
development a parallel environment capable image registration software library.
Material and methods: We formed a test environment — including mathematical
phantoms and a Monte-Carlo based simulator — with which the implemented
algorithms can be validated even in the hardware engineering phase. The developed
software package is capable of perform a test, that help us to specify a high
calculation capability dedicated reconstruction server.
Result: With this achievement we managed to realize the principal component of
a small animal PET scanner software system that can be used for modern biomedical
studies.
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INVESTIGATION ON LEAKAGE AND ORGAN UPTAKE
OF 186RE RADIOCOLLOIDS IN RABBIT AND RAT USING NANOSPECT/CT
D. Máthé1, L. Balogh1, A. Polyák1, R. Király1, L. Kõrösi1, I. Müller2, N. Schramm3,
G.A. Jánoki1
1Department of Applied Radioisotopes, National “Frédéric Joliot-Curie” Institute
of Radiobiology and Radiohygiene, Budapest, Hungary
2Mediso Kft., Budapest, Hungary
3Bioscan Inc., Washington, United States
Aim: Determination of the intra-articular and extra-articular biodistribution
of radioactivity following injection of 186Re in healthy rabbits and rats.
Material and methods: Studies have been performed using a Mediso-Bioscan
NanoSPECT/CT small animal imager. 10 MBq of 186Re sulphur colloid was injected
intravenously for 15 Wistar rats and SPECT/CT scans were made 30 min, 1 h and
3 hours post injections. For paraarticular injections, 10 MBq of sulphur colloid was
injected through the knee joint of 2 rats. SPECT/CT was performed 30 min and 1 h
post injection. Two healthy NZW rabbits were killed 3 h post injection of 18 MBq of
186Re sulphur colloid, their injected limbs removed and ex vivo SPECT/CT was
performed on the intact organs.
Results: In intravenously injected rats, liver and spleen were the only organs where
an uptake could be visualized. In the case of paraarticularly injected radiocolloids
besides visualization of spleen and liver, SPECT/CT made possible the detection of
the inguinal lymph node as a known predilectory leakage site. Results of rabbit
ex vivo imaging show that the sulphur colloid is unevenly distributed in the intraarticular
space.
Discussion: NanoSPECT/CT is an excellent high definition (0.6 mm) tool to perform
in and ex vivo non invasive studies in small animals. This method allowed accurate
in vivo identification and examination of organs collecting uptake after intra-articular
injection of a radiocolloid, thereby opening novel perspectives in preclinical
radiosynovectomy research.
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INVESTIGATION OF ACCUMULATION OF 11C-CHOLINE, A PET TUMOR
DIAGNOSTIC TRACER IN CANCER CELLS
T. Miklovicz1, J. P-Szabó1, P. Mikecz1, Z.T. Krasznai2, Z. Kovács3, T. Nagy1,
Z. Hendrik1, T. Márián1
1Department of Nuclear Medicine, Medical and Health Science Centre, University
of Debrecen, Debrecen, Hungary
2Department of Obstetrics and Gynecology, Medical and Health Science Centre,
University of Debrecen, Debrecen, Hungary
3Institute of Nuclear Research, Debrecen, Hungary
Background: 11C-choline is highly accumulated in cancer cells because of their
increased choline kinase activity. There is a growing importance of 11C-choline PET
investigations in the diagnosis of tumorous patients.
Aim: To study the effect of various pharmaceuticals and ligands on the 11C-choline
accumulation in tumor cells.
Material and methods: The accumulation of radiopharmaceuticals in different cancer
cells was measured a calibrated gamma-counter.
Results: The 11C-choline accumulation of the MDR1 gene (Pgp) expressing multidrug
resistant cancer cells was significant higher than that of the Pgp negative ones.
Some cytostatics, pharmaceuticals, channel blockers and Pgp substrates
dramatically modified the 11C-choline uptake of the cancer cells. Verapamil, bepridil,
amylorid analogs and daunorubicin in a dose dependent manner decreased the
accumulation of 11C-choline. Paclitaxel treatment did not modify the 11C-choline
uptake of the transformed cells.
Conclusion: The knowledge, how the different pharmaceuticals used in
chemotherapy modify the 11C-choline accumulation of the Pgp-positive and negative
cells may contribute a more accurate PET diagnosis. 11C-choline PET investigations,
using adequate protocols may help to reveal the multidrug resistance of tumors.
EVALUATION DIFFICULTIES IN THE COURSE OF BONE SCANNING
FOLLOWING A RADICAL SMALL PELVIC OPERATION
G. Pusztay1, Z. Nemessányi1, J. Vancsura2
1Department of Nuclear Medicine, Semmelweis Hospital of Kiskunhalas PC,
Kiskunhalas, Hungary
2Department of Urology, Semmelweis Hospital of Kiskunhalas PC, Kiskunhalas,
Hungary
Making a report requires adequate anatomical, physiological and pathophysiological know-
ledge from the analyzing doctor. However in postoperative situations it is essential to be
aware of operative solutions, as well. The lack of this in case of unusual scintigraphic
appearance may lead to false positive findings, or may require further — unnecessary
— examinations, delaying the establish of proper diagnosis. To make a correct report there-
fore it is important, that the doctor should include the anamnestical facts and operative
solutions in connection with the examination in the document requiring it.
In one of our bone scan cases because of lack of the above mentioned information we had
to engage ourselves in a lengthy investigation to clear up the applied operative solution,
which was essential to make up a correct — not false positive — report. In our other case
the sufficient information made the correct interpretation possible very soon.
INTEGRATED EVALUATION OF PANORAMIC X-RAY
AND SPECT OF THE TEETH
J. Varga1, J. Borbély2, C. Dobó Nagy2, E. Takács3, I. Szilvási3, P. Fejérdy2
1Department of Nuclear Medicine, University of Debrecen, Debrecen, Hungary
2Department of Prosthodontics, Semmelweis University, Budapest, Hungary
3Kútvölgyi Clinical Unit, Semmelweis University, Budapest, Hungary
Aim: Teeth are traditionally visualized using panoramic X-ray; however, inflamed sites have
higher contrast in bone scintigram. Our purpose was the registration and fused display of
images from both modalities.
Material and methods: Panoramic X-ray and Tc-99m MDP SPECT of twenty patients were
performed after attaching four reference sources to the facial skin that visualized on both
modalities. We created panoramic images by projecting SPECT slices to a cylindrical sur-
face, then registered the 4 reference points, and superimposed the transformed colored
scintigram onto the grayscale X-ray image.
Results: Anatomic sites cannot be localized on both X-ray and scintigraphic images with
sufficient accuracy, so external markers were required. The selected four points (subnasal,
gnathion and both anguli) were enough to fit both vertical distance and azimuth angle.
Conclusion: Panoramic view obtained from scintigraphy adds valuable functional information
to X-ray. They can be suitably coregistered using four external markers.
BONES
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ENDOCRINOLOGY
THE ROLE OF 131I-MIBG SCINTIGRAPHY IN UNCOMMON CASE
OF PHAEOCHROMOCYTOMA
Judit Bereczné Apostol1, Bertramné Wyrwich1, Andrea Homonnai1, Lívia Csirmaz2
1H.M.Ö. Markhot Ferenc Hospital. Nuclear Medicine Department, Eger, Hungary
2H.M.Ö. Markhot Ferenc Hospital, Endocrinology Ambulance, Eger, Hungary
Aim: The aim of the study is to determine the role of 131I-MIBG scintigraphy
in an uncommon case of phaeochromocytoma.
Material and methods: Following the routine pretreatment 40 MBq 131I-MIBG has
been administrated in intravenous route. We obtained 48 hours images with
MB-9200 Gamma camera. MRI study revealed a 3 cm diameter terime in the right
suprarenal glandular region, and a 1 cm diameter lesion in the opposite side.
Using contrast MR method neoplasmatic origin has been suspected.
Results: In the right supragladular region a large intensive radiotracer activity could
be observed. In the left supraglandular and in the other examined regions no significant
activity has been detected. Following right sided laparoscopic adrenalectomy
the diagnosis of phaeochromocytoma was cleared in histopathologic way. 2 years
after control MRI showed, that the previously detected terime in the left suprarenal
gland doubled in size. Nuclear medicine scans revealed a nut size lesion with marked
activity in the target region. Suspected MEN I. or II. syndrome have been excluded by
genetic examinations.
Conclusions: The detection of hormonal active phaechromocytomas using nuclear
medicine methods is a useful diagnostic approach, even in complicated cases.
The sensitivity correlates with the size of the lesion.
QUANTITATIVE THYROID SCINTIGRAPHY IN CONGENITAL
HYPOTHYROIDISM
Klára Buga1, Ágota Muzsnai2, Zoltán Nagy1, Zsolt Varga1, István Szilvási1,
Ferenc Péter2
1Department of Nuclear Medicine, National Medical Center, Budapest, Hungary
2Children's Hospital Buda, Budapest, Hungary
Aim: clinical usefulness of quantitative Tc-99m-pertechnetate thyroid scintigraphy
(QTS) in children with congenital hypothyroidism was studied.
Material and methods: 80 patients with CH were examined. All patients underwent
the so-called T3 withdrawal test to differentiate permanent and transitory
hypothyroidism. In vitro measurement of thyroid hormone serum concentration
and QTS with 20-minute Tc-uptake) were performed. All patients had previous
ultrasound examination (US). Tc-uptake values were defined as low (below 0.5%),
normal (0.5–5.0%) and high (above 5.0%).
Results: 78 children had permanent, 2 had transitory hypothyroidism. Both patients
had normal US, scintigram and Tc-uptake value. 41 patients had normal or enlarged
thyroid in the physiologic location by US, but only 20 of them were visualized
by scintigraphy. 13 out of these 20 children had normal, 7 had elevated Tc-uptake
values. 11 patients with normal and all 7 patients with elevated Tc-uptake had
permanent hypothyroidism.
Conclusions: Pathomechanism of CH is important to inform the mother regarding
next gravidity. If normal thyroid tissue is visualized on the neck by US, QTS seems
to be useful in the differential diagnosis of CH.
INTRAOPERATIVE PARATHYROID ASPIRATION AND HORMONE ASSAY
L. Duffek1, J. Horányi2, T. Györke1, K. Hüttl1
1Department of Diagnostic Radiology and Oncotherapy, Semmelweis University,
Faculty of Medicine, Budapest, Hungary
21st Department of Surgery, Semmelweis University, Faculty of Medicine, Budapest,
Hungary
Aim: Conventional parathyroidectomy is a difficult operation and the unsuccessful
rate is 5% to 10% . In order to improve the efficiency intraopertative quick aspiration
parathyroid hormon assay were used.
Material and methods: Intraoperative aspiration PTH concentration was determined
by 82 patients. They under went parathyroiectomy from March 2006 to January 2007
with diagnosis of primery hyperparathyroidism. Each specimen was divided into tubes
and was stored in four Celsius until the quick PTH assay start. The aspiration tissue
parathyroid hormone concentration was measured by cisbio quick IRMA method.
Results: Ex vivo parathyroid adenoma sample PTH concentration was always between
3500–9800 pg/ml obtaining by the semi-quantitative tissue hormone determination.
PTH concentration of the aspiration thyroid tissue was beetwen 0.1–5.0 pg/ml.
Conclusion: PTH measurement from intraoperative aspiration of suspected
parathyroid adenomas is clinically useful for patients. In case of hyperparathyroidism,
the combined use of intraoperative aspiration hormone assay, gamma probe
measurements and quick PTH examination  improve the success rate and decrease
the duration of parathyroidectomy as well as give a chance to apply minimal invazive
parathyroidectomy.
RETROBULBAR 99MTC-DIETHYLENETRIAMINE-PENTAACETIC-ACID
UPTAKE PREDICTS THE EFFECTIVENESS OF IMMUNOSUPPRESSIVE
THERAPY IN GRAVES' OPHTHALMOPATHY
L. Galuska1, B. Ujhelyi3, J. Varga1, L. Szabados1, E. Balazs2, M. Bodor3, A. Erdei3,
Z. Karanyi3, A. Leovey3, F.Z. Szucs4, K.D. Burman5, A. Berta2, E.V. Nagy3
1Institute of  Nuclear Medicine, University of Debrecen Medical and Health Science
Center, Debrecen, Hungary
2Department of Ophthalmology, University of Debrecen Medical and Health
Science Center, Debrecen, Hungary
3Department of Internal Medicine, University of Debrecen Medical and Health
Science Center, Debrecen, Hungary
4Department of Radiology, University of Debrecen Medical and Health Science
Center, Debrecen, Hungary
5Endocrine Section, Department of Medicine, Washington Hospital Center,
Washington, United States
Aim: We aimed to show if 99mTc-DTPA SPET is able to predict the success
of imunosuppressive treatment (IT) in Graves’ ophthalmopathy (GO).
Material and methods: 24 pts with GO (15 women and 9 men) were studied with GO
and signs of orbital autoimmune process (CAS ≥ 4) All received corticosteroid
treatment and 6 were additionally treated with orbital irradiation. DTPA SPET was
performed before, and 3 to 24 months after the IT. Orbital DTPA uptakes were quantified
and compared before and after IT. The calculations were performed for the entire
orbit ROI as well as the anterior and posterior segments separately. The control group
consisted 17 pts who had no thyroid disease.
Results: In the control group, the DTPA uptake of the orbit as a whole, the anterior,
(a) and posterior (p) segments were 7.9 ± 2.6, 8.8 ± 3.0 and 6.6 ± 2.0 Bq/cm3
(mean ± SD) respectively. The mean DTPA uptake of the 48 orbits of GO pts was
higher before IT than after therapy (8.92 ± 2.31 Bq/cm3 and 7.67 ± 3.82 Bq/cm3,
respectively, p = 0.0003). The a and p segment values correlated with those
of the entire orbit. Of the 35 orbits with an initial DTPA uptake £ 10.07 Bq/cm3
in the p segment, 11% has improved, while of those 13 orbits with an initial DTPA
uptake above 10.07 MBq/cm3, 77% has improved.
Conclusions: For a favourable treatment outcome, the positive predictive value
of an initial DTPA uptake > 10.07 was 81.25 %, while a negative predictive value
of a DTPA uptake  £ 10.07 was 89.74 %. DTPA uptake above 10.07 predict responders,
while pts with DTPA uptake below this are non responders.
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THYROID DIAGNOSTIC AND THERAPY PROGRAM PACKAGE
B. Kári1, L. Font2, J. Östör2, L. Nagy2, L. Bajnok3, K. Zámbó4, A. Konrády5
1Department of Diagnostic Radiology and Oncotherapy, Faculty of Medicine,
Semmelweis University, Budapest, Hungary
2MEDISO Ltd., Budapest, Hungary
31st Internal Clinic, University of Pécs, Pécs, Hungary
4Department of Nuclear Medicine, University of Pécs, Pécs, Hungary
5Jávorszky Ödön Hospital Department of Isotope Ambulance, Vác, Hungary
Complex 99mTc/131I diagnostic and 131I therapy program package has been created
for InterViewXP™ DICOM version in order to extend the versatility of Nucline™ TH
dedicated thyroid camera. The fundament of therapy dose calculation is the thyroid
mass estimation and iodine uptake determination. Geometry (lobes, nodules area
and shapes) of the high quality thyroid scintigraphy — 99mTc/131I — with well calibrated
pixel-size provides the way of mass estimation. Most of the publication based
estimation methods are built in the system by user definable way. More possibilities
are available for iodine uptake determination too. Camera and ROI based method
as well as single detector based uptake evaluations are available. The user may link
together these procedures into a single clinical program. Even though, one of the
menu selectable therapy calculations may up-link to the diagnostic procedure
creating the complex therapy and diagnostic frame work. These algorithms widely
cover the current possibilities of thyroid diagnostic and therapy.
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THE CASE OF OLD AGE TSHS II
M. Marik, A. Tombacz, A. Homonnai
Department of Nuclear Medicine, Markhot Ferenc County Hospital, Eger,
Hungary
Aim: It has been proven in our former studies that in patients suffering from meno
and postmenopausal, subclinic hyperthyreoses elevated levels of FSH-LH
are responsible for higher levels of TSH. The aim of our current work was to examine
the possibilities of proper diagnostics of old age subclinic hyperthyreoses.
Material and methods: We attempted to detect real hyperthyreosis by determining
the elevated level of FT4 in patients above the age of 55. The increased level of FT4
of these people had been defined as normal TSH in daily routine measurements but
they were no longer observed. We performed FT4 measurements of the samples
of 100 patients by Isodata and Stratec 300 devices (resources of the Isotope Institute).
Results: 29 samples indicated normal thyroid function by showing normal FT4 values.
Out of the higher values of FT4, 43 were slightly elevated (25.0–30.0 pmol/l), while
23 of them were considered as elevated (more than 30.0 pmol/l).
Conclusions: Regarding patients above the age of 50 the posterior FT4
measurement is reasonable even in the case of normal TSH results, since we have
detected values of FT4 suggestive to hyperthyreosis in 71 percents of the observed
cases.
THE SIGNIFICANCE OF SPECT INVESTIGATION DURING PARATHYROID
SCINTIGRAPHY IN PRIMARY HYPERPARATHYROIDISM
E. Palócz1, J. Horányi2, M. Szathmári3, I. Takács3, L. Duffek1, B. Kári1,
R. Mészáros1, T. Györke1
1Department of Diagnostic Radiology and Oncotherapy, Faculty of Medicine,
Semmelweis University, Budapest, Hungary
21st Department of Surgery, Faculty of Medicine, Semmelweis University,
Budapest, Hungary
31st Department of Internal Medicine, Faculty of Medicine, Semmelweis University,
Budapest, Hungary
Aim: To investigate the significance of SPECT investigation (SI) during parathyroid
scintigraphy (PTS) in primary hyperparathyroidism.
Material and methods: We evaluated PTSs of 39 patients (31 females, 8 males)
performed in 2 years (2005–2006) with a final diagnosis based on surgery, histology
and biochemistry. After i.v. injection of 99mTc-MIBI early (n = 39) and late (n = 38)
planar (P), early (n = 39) or late (n = 2) SPECT, with 99mTc-pertechnetate on other
day P and subtraction (n = 34) images were obtained.
Results: Sensitivity of PTS for 43 lesions (L) (37 adenoma, 3 hyperplasia, 3 cancer)
removed by 44 surgery was 95.3% without false positive finding. 4 Ls were detected
only by SI. SI had a high impact on diagnosis of 17 further Ls; in 20 Ls the results
of P investigations were verified and an improved L localisation was provided.
Conclusion: In a significant number of cases SPECT had a great impact on
the effectiveness of MPS; in unequivocal Ls an improved L localisation was provided.
SPECT should be performed as a routine part of MPS.
FDG-UPTAKE OF THE THYROID GLAND IN PATIENTS WITH ABNORMAL
THYROID FUNCTION OR WITH PRESENCE OF THYROID ANTIBODIES
A. Radácsi1, Z. Lengyel2, E. Takács1, K. Benedek1, Sz. Szakáll2, I. Szilvási1
1Department of Nuclear Medicine, Kútvölgyi Clinical Center, Semmelweis
University, Budapest, Hungary
2POZITRON — Diagnostic Kft., Budapest, Hungary
Aim: Correlation between thyroid uptake of F-18-fluorodeoxyglucose (FDG)
and thyroid function or presence of thyroid antibodies were studied.
Material and methods: Serum concentration of TSH, FT3, FT4, anti-TPO
and anti-Tg were measured in 105 consecutive patients admitted to oncological
(thyroid except) FDG PET examination. SUV of thyroid gland were calaculated.
Results: In 88/105 cases thyroid function was normal. 4 patients had subclinical
hyperthyroidism, 10 patients had subclinical hypothyroidism and 3 patients
had autoimmune hypothyroidism. The SUV (mean ± SD) of the thyroid was
significantly elevated in patients with hypothyroidism (1.46 ± 0.92 vs. 1.05 ± 0.06).
In euthyroid patients a negative correlation between SUV and FT4 concentration
(r = –0.29, p < 0.05) was found. SUV of FDG was significantly elevated
in patients with high anti-TPO (1.43 ± 0.66 vs. 1.07 ± 0.13) or with high anti-Tg
(1.84 ± 0.84 vs.1.04 ± 0.08) serum level as well.
Conclusions: Thyroid FDG uptake is higher in patients with high serum concentration
of antithyroid antibodies. Diffusely increased FDG-uptake might refer to chronic
thyreoiditis. Explanation of the inverse correlation between FDG uptake and FT4
concentration in normothyroid subjects needs further studies.
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EXPERIENCES WITH WHOLE-BODY SCAN AFTER HIGH-DOSE ABLATION
OF THYRIOD REMNANT
M. Sarkadi1, E. Mezõsi2, L. Bajnok2, V. Deák2, Z. Keszthelyi2, E. Schmidt1,
Z. Szabó1, K. Zámbó1
1Department of Nuclear Medicine, University of Pécs, Pécs, Hungary
21st Department of Internal Medicine, University of Pécs, Pécs, Hungary
Aim: To compare the efficacy and safety of recombinant human TSH (rhTSH) to the
conventional remnant ablation with thyroxine withdrawal in patients with thyroid
cancer.
Material and methods: High-dose ablation (3700 MBq) of thyroid remnant was
performed in 32 patient from January 2006, with rhTSH in 12 patients (2 men,
10 women, 46 years, 23–63), and conventional protocol in 20 patients (2 men,
18 women, 48 yeras, 16–76). TSH and thyroblobulin (Tg) levels were measured
before and after the ablation. Whole-body (5 cm/min) and anterior jugular scans
(100 k) were established in all patients 6 days after the treatment. The counts/million
(C) of the whole-body scan and C/Tg (before treatment) rate was calculated.
The enhancement of the radioiodine in the remnant and in other localization was
observed on both imaging.
Results: The C/Tg ratio was higher in the patients prepared with rhTSH (0.33/0.10,
p £ 0.05) whereas the whole-body C value was lower (0.18/0.71, p £ 0.05) comparing
to the patients with conventional therapy. Remnant thyroid activity was found in
27 patients, iodine enhancement in other localization was found in 11 patients,
at whom CT examinations were performed, too.
Conclusions: 1. The rhTSH-prepared patients maintained a higher quality of life
during the ablation. 2. The radiation exposure to the blood is less while the efficacy
of the treatment is equally good. 3. The whole-body and jugular scans are very
useful in the investigation of thyroid remnant and metastases in the region of neck
and chest, however it can be evaluated with caution in the abdominal region.
SUCCESSFUL LOCALIZATION OF BRONCHIAL CARCINOID CAUSING
ECTOPIC CUSHING'S SYNDROME BY 111-IN-OCTREOTIDE SCINTIGRAPHY
E. Schmidt1, Z. Szabó1, Z. Nagy2, B. Bódis2, E. Mezõsi2, L. Bajnok2, K. Zámbó1
1Department of Nuclear Medicine, University of Pécs, Pécs, Hungary
21st Dept. of Internal Medicine, University of Pécs, Pécs, Hungary
Aim: Cushing's syndrome due to ectopic ACTH secretion is difficult to diagnose
and treat. Up to 80% of ectopic ACTH-producing tumors have somatostatin
receptors, therefore 111-In-octreotide scintigraphy is a useful method in the diagnosis
of this disease.
Material and methods: A 43-year-old woman was investigated with severe Cushing's
syndrome of two years duration. The ACTH was moderately elevated (150–250 pg/
/ml), 2-d small dose dexamethasone suppression test was positive, however,
2-d high dose dexamethasone test showed suppressible cortisol level. Inferior
petrosal sinus sampling (repeated twice) supported ectopic ACTH production,
no response to CRH stimulation was detected. Pitutitary MRI (twice), chest CT scan
(three times), chest MRI, abdominal CT scan (twice) failed to localize the source
of ACTH secretion. Octreotide scintigraphy performed in another institute one year
ago was also negative. Calcitonin, urine catecholamines and urine 5-hydroxyindole-
acetic acid measurements gave negative results.
Result: The localization of the tumor was attempted repeatedly by octreotide
scintigraphy. Anterior and posterior chest and abdominal static and SPECT images
were performed 24 and 48 hours after the injection of 111-In-octreotide. A very
intensive uptake was found in the left side of the mediastinum in both time. Abdominal
examination did not reveal any abnormality. The tumor was removed during chest
surgery. The histological diagnosis was typical bronchial carcinoid tumor with intense
ACTH positivity.
Conclusion: This case indicates that 111-In-octreotide scintigraphy could
be successfully used to identify and localize ectopic ACTH-producing bronchial
carcinoids.
RESULTS OF INDIVIDUAL RADIOIODINE DOSE CALCULATION
IN HYPERTHYREOIDISM
Z. Szabó1, E. Mezõsi2, L. Bajnok2, Z. Keszthelyi2, Z. Nagy2, B. Bódis2, V. Deák2,
E. Schmidt1, K. Zámbó1
1Department of Nuclear Medicine, University of Pécs, Pécs, Hungary
21st Department of Internal Medicine, University of Pécs, Pécs, Hungary
Aim: A total of 154 patients with hyperthyroidism received 161 individually calculated
radioiodine treatments between October 2004 and December 2005. M/F ratio was
25/129, age distribution: 26-87 years, mean age: 60 years. Forty-six patients had
toxic adenoma, 25 patients were treated with toxic multinodular goiter, 83 patients
with Graves’ disease.
Material and methods: The target dose was calculated according to the etiology
of hyperthyroidism: 350 Gy in toxic adenoma, 150 Gy in toxic multinodular goiter
and 70–100 Gy in Graves’ disease depending on the size and nodularity of the
thyroid. The estimate of the thyroid mass was based on the scintigraphy, the
calculation of the biological half life was simplified by the late iodine uptake (7. day)
measurement, according to the previous investigations. The activity of radioiodine
was calculated by the following formula: 3.5 x thyroid mass (g) x target dose (Gy)/
/late iodine uptake (%).
Results: The average radioiodine dose was 378 MBq (min. 100, max. 1180, 1.
quartilis 230, median 340, 3. quartilis 500 MBq). Six and 12 months after the treatment,
follow-up data were available in 91% and 83% of patients, respectively. The
hypothyroidism/euthyroidism/hyperthyroidism ratio was 23/51/26% 6 months and
22/49/16% 12 months after the radioiodine treatment. Eighteen hyperthyroid patients
at the 6-month follow-up were selected for a second radioiodine treatment, these
patients were not evaluated during the 12-month control. According to the etiology
of thyrotoxicosis, the distribution of hypo/eu/hyperthyroidism at the 6-month follow-
up was 11/80/9% in toxic adenoma, 5/52/43% in toxic multinodular goiter, 35/35/
/30% in Graves’ disease, respectively.
Conclusion: Our dose-calculation method resulted in excellent success rate in toxic
adenomas, good success rate in Graves’ disease even in international comparison
but the results were not satisfactory in toxic multinodular goiters. Difficulties to
determine the targeted thyroid mass in this entity may be responsible for the treatment
failure.
IMPACT OF I-131-SPECT/ SPIRAL-CT ON THE N-STAGING OF DIFFERENTIATED
THYROID CARCINOMA AT FIRST RADIOABLATIVE THERAPY
A. Szikszai, W. Römer, V. Schulz, T. Kuwert
Nuklearmedizinische Klinik, Universität Erlangen-Nürnberg, Germany
Aim: The purpose of this study was to determine the diagnostic impact of I-131-
-SPECT/ spiral-CT on nodal staging of patients with thyroid carcinoma (DTC) at the
first ablative radioiodine therapy (ART).
Material and methods: 07/05–08/06, 29 patients had radioablation of thyroid
remnants (4.6 ± 1.8 GBq I-131) for DTC. All patients underwent planar scintigraphies
of the neck as well as cervical SPECT/spiral CT. SPECT/CT was performed using
a hybrid camera combining a double-headed SPECT camera and a two-slice CT
scanner (Symbia T2, Siemens). Two observers evaluated the planar scans and the
SPECT/CT images for pathological tracer uptake independently from each other
and from the clinical findings.
Results: In 8 patients from 29 were atypical Iodine-Uptake observed on the planar
imaging, 6 of them were seen with the SPECT/CT as thyroid residue in the region of
the Lobus pyramidalis. In 2 cases the lesions were simulated by contamination on
the skin.
At 6 patients of 29 (20.7%) were 131-iodine hot spots caused by lymph nodes
metastases detected with the SPECT/CT. None of these lesions could be
diskriminated from the thyroid remnant tissue on the planar images. In 3 patients of
them lymph node metastasis were already known postoperatively (N1), in the other
3 patients reclassification was necessary.
Conclusions: Integrated 131I-SPECT/spiral CT was found to have an additional
value over planar imaging in patients with thyroid cancer at the time of the
radioablation. Further examination is needed to show, how the therapeutical
procedure changes with the early detection of lymph node metastases.
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THE IMPORTANCE OF MRI-PET REGISTRATION IN CLINICAL ROUTINE
M. Emri1, G. Opposits1, L. Trón1, Á. Klekner2, L. Novák2, J. Kollár3, L. Bognár2,
E. Berényi3
1Institute of Nuclear Medicine, University of Debrecen, Hungary
2Department of Neurosurgery, University of Debrecen, Hungary
3Department of Radiológy, University of Debrecen, Hungary
Aim: Registered images produced by MRI based multi-modality image processing
are essential tools of diagnostic and surgical planning of neurological
and neurosurgical diseases. The aim of this study was to investigate how fused
images produced by various MRI (T1, T2, fMRI, DTI, MRS) and PET (FDG, Metionine)
data can be used in clinical routine.
Material and methods: In our study the complex multi-modality tomographic data
sets of 6 patients (3 glioblastoma, 2 oligoastrocitóma és 1 pilocitás astrocitoma)
were used. For the image registration as well as the production of 2D- and 3D fused
images free, commercial and in-house developed software were utilized.
Result: We found that our images significantly assisted clinicians in preparing
therapeutic and surgical plans. Optimizing the established software and automatizing
image registration tasks needs further development.
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DICOM AND MULTI-MODALITY BASED — INTERVIEWXP™ DCM
— IMAGE PROCESSING SYSTEM
B. Kári1, A. Farkas2, J. Östör2, Zs. Hegyi2, J. Turák2, L. Nagy2, F. Kovács3,
O. Pártos4, T. Györke1
1Department of Diagnostic Radiology and Oncotherapy, Faculty of Medicine,
Semmelweis University, Budapest, Hungary
2MEDISO Ltd., Budapest, Hungary
3Uzsoki Hospital, Budapest, Hungary
4Department of Nuclear Medicine, Budapest, Hungary
5Gottsegen György Hungarian Institute of Cardiology, Department of Isotope
Diagnostic, Budapest, Hungary
Continuous development of the functional imaging systems as well as construction
of NanoSPECT/CT™ induced Mediso Ltd. to apply new software technology on the
field of image processing and management. Breakthrough of the hybrid systems
and multi-modality applications demanded the uniform image managing as well as
the creation of simultaneous image display and fusion techniques. Consequently,
the DICOM version of graphical based InterViewXP®™ has been created.
Full possibilities of the system can be accessed only through DICOM 3.0 services.
Database of the DICOM server is MS-SQL 2005 with Windows®XP SP2 op. system.
Installation of a local PACS is warmly suggested for routine application in order to
connect directly with the evaluation workstations including the regional RIS interfaces.
Other program packages (ECTB V 3.0, PMOD fusion) may up-link easily to
InterViewXP™ too by common database due to the DICOM surface. Such a complex
system may provide the complete image processing and managing services in
a particular department.
EXPERIENCES WITH SPEECH RECOGNITION SYSTEM IN THE REPORTING
OF NUCLEAR MEDICINE INVESTIGATIONS
T. Györke1, A. Decker2, R. Koltai3, B. Kári1
1Department of Diagnostic Radiology and Oncotherapy, Faculty of Medicine,
Semmelweis University, Budapest, Hungary
2ISH Ltd., Budapest, Hungary
3Medisoft Speech Ltd., Budapest, Hungary
Aim: To demonstrate the usefulness of speech recognition system (SRS) based
on our experiences in reporting nuclear medicine investigations by SRS and in the
development of nuclear medicine vocabulary of SRS.
Material and methods: The Speech-Magic™ SRS based on Speech Recognition
Technology provided by Philips and integrated into the Hospital Information System
(e-MedSolution) by ISH Ltd. with the contribution of Medisoft Ltd. has been available
at our institute since March 2006. At installation the vocabulary of SRS contained
20140 Hungarian phrases for radiology reporting.
Results: We performed 1167 dictation. 946 new phrases have been entered into
the vocabulary of SRS. Currently the reporting of the most frequent investigations
at our nuclear medicine department can be performed fast and almost entirely
correctly by SRS.
Conclusion: SRS is a useful tool for the reporting of nuclear medicine investigations.
Based on replacement of human work power it should be cost effective on a long
term basis.
INSTRUMENTATION AND PHYSICS
TESTING AND VALIDATING OF A PARALLEL IMAGE RECONSTRUCTION
SOFTWARE PACKAGE
S.A. Kis1, L. Trón1, G. Opposits1, P. Veres1, Á. Pányik1, G. Kovács1, L. Balkay1,
L. Pohubi2, Á. Szlávecz3, J. Molnár4, L. Galuska1, M. Emri1
1University of Debrecen Institute of Nuclear Medicine, Debrecen, Hugary
2MEDISO Ltd., Budapest, Hugary
3BME, Department of Information Technology, Budapest, Hungary
4Institute of Nuclear Research of the Hungarian Academy of Sciences, Debrecen,
Hungary
Aim: Our institute as a consortium member plans to build a demonstration version
of a full ring small animal PET scanner. The software system attending this device
has to accommodate full 3D- and conventional 2D reconstruction algorithms.  For
the huge calculation and storing capacity required by 3D methods demand
development a parallel environment capable image registration software library.
Material and methods: We formed a test environment — including mathematical
phantoms and a Monte-Carlo based simulator — with which the implemented
algorithms can be validated even in the hardware engineering phase. The developed
software package is capable of perform a test, that help us to specify a high
calculation capability dedicated reconstruction server.
Result: With this achievement we managed to realize the principal component of a
small animal PET scanner software system that can be used for modern biomedical
studies.
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PARADOXES OF MEASUREMENT CURVES
G. Tiszay, J. Vincze
HHEIF, Budapest, Hungary
In the past two decades in nuclear medicine the analog measurement techniques
have been replaced by digital techniques which can be processed more comfortably.
Besides their numerous advantages, digital techniques do have a main
disadvantage: namely the fact that they are less compatible with living organisms.
Digital measurement provides such accuracy of time, size, and other parameters
that they make no sense in biology. This is all the more true for nanotechnology,
when microseconds and nanometric orders of magnitude are measured, while the
living matter is not present any longer, since at such dimensions the human race
does not display the characteristics of living matter through the course of phylogenetic
development. By illustrating the statement above with concrete examples, this essay
would like to remind scientists working with nuclear measurement to take into
consideration the time and space limits typical of the human organism as a biological
entity.
USEFULNESS OF NITRIDO LABELLING TECHNIQUE IN THE DEVELOPMENT
OF DIAGNOSTIC AND THERAPEUTICAL RADIOPHARMACEUTICALS
J. Környei1, M. Antalffy1, E. Szemenyei2, G. Tóth2, M. Paál3, A. Duatti4
1Institute of Isotopes Co. Ltd., Budapest, Hungary
2Biological Research Center, Institute of Biochemistry, Isotope Laboratory,
Szeged, Hungary
3St. George Hospital of Fejér County, Székesfehérvár, Hungary
4University of Ferrara, Department of Nuclear Medicine, Ferrara, Italy
Aim: Usefulness of nitrido 99mTc and 186/188Re labelling were investigated in case of
some sulphur containing as well as sulphur-free ligands. Indication fields of these
potential radiopharmaceuticals are apoptosis imaging, bone scintigraphy and
therapy, liver therapy.
Material and methods: Derivatized fragments of Annexin-V were labelled with 99mTc
by using nitrido technique in the frame of a CRP supported by the IAEA. Beside this,
both 99mTc and 186/188Re labelling of Multibone kit via nitrido intermediers were also
investigated. Furthermore, optimation of a kit was elaborated, resulting in (R∫N)-
-diethyl-dithiocarbamate which can be dissolved in Lipiodol completely.
Results: Yields of 90–99% were obtained in case of the nitrido-99mTc labelling of the
peptides and Multibone. The nitrido-99mTc peptides possess extremely high stability.
Nitrido-186/188Re labelling of “Lipiokit” and Multibone was accomplished with a yield
of 92 ± 5% and less than 60%, respectively.
Conclusion: Usefulness of nitrido labelling technique was proved in 99mTc labelling
of Annexin fragments as well as in rhenium labelling of Lipiodol. The “Lipiokit” may
be prepared as clinical investigational product in the near future.
ANALYTICAL AND BIOLOGICAL EXAMINATION OF 111-IN-DOTA
ANTIFERRITIN
L. Kõrösi, L. Balogh, A. Polyák, D. Máthé, Gy. A. Jánoki
Department of Applied Radioisotopes, National “F.J.C.” Research Institute
for Radiobiology and Radiohygiene, Budapest, Hungary
111-In-DOTA-Antiferritin was developed for examination of lymphoma disease. We
studied the chemical stability of 111-In labelled DOTA-Antiferritin with different
analytical methods in vitro. The in vivo studies were done with Beagle dogs. After
injecting labelled compound measured serum stability, blood clearance and activity
distribution in different organs by scintigraphical methods. In the first step  we worked
out optimum conditions of labelling procedure with 111-In. 111-In-DOTA-Antiferritin
was prepared in 0.1 M, pH 6 ammonium acetate buffer + 10% 50mM EDTA Incubated
at room temperature for 60 min. The radiochemical efficiency was determined by
thin layer chromatography in “labelling buffer”. The radiochemical purity was
measured with High Pressure Liquid Chromatography, using Gel Filtration Column.
The HPLC buffer was 0.1 M pH 7 sodium phosphate + 2 mM EDTA, running time
30 min., injected volume 20 µL. Using these sensitive radio-analytical methods
studied serum stability and fragment activity in urine of 111-In-DOTA-Antiferritin. In
these case 20 µL serum or urine was injected. Serum and urine samples were taken
2 minutes, 1, 6, 12, 24, 48 hours and 3, 5, 7, days after injection. The r radiochemical
efficiency of the compound — using both analytical methods — 80–85%,
decomposition measured only after 48 hours and total fragmentation after 72 hours.
In the urine after 1 hour few fragment activity detected and later showed increase.
The labelled antibody was injected in 5-5-healthy Beagle dogs and made initial
dynamic study (0–30 min.) concerning static ventrodorsal (72 h) and right lateral
opinion for examination of radioactivity distribution. ROI methods was used to
quantific and to have data for the calculation of dosimetric and pharmacokinetic
parameters.
SYNTHESIS AND 99MTC-LABELLING A PEPTIDE CLAIMING THE DETECTION
OF APOPTOSIS IN VIVO
E. Szemenyei1, G. Tóth1, K. Kothari2, J. Környei3
1Biological Research Center, Institute of Biochemistry, Isotope Laboratory,
Szeged, Hungary
2Bhabha Atomic Research Centre, Radiochemistry and Isotope Group, Mumbai, India
3Institute of Isotopes Ltd., Budapest, Hungary
Aim: Our aims were the synthesis, study of the stability and labelling with 99mTc of
the 13 amino acids long Annexin-V protein segment, which protein plays role in
detection of the apoptosis.
Material and methods: The peptide (AQVLRGTVTDFPG) was synthetized by solide
phase peptide synthesis both in amide and free acid forms. The purification and the
control of the purity were performed by RP-HPLC. The peptide structure was identified
by MALDI-TOF. We used a new labelling method: “nitrido-labelling”. The biological
activity of the labelled compoud was evaluated on HL-60 human leukemia cells.
Results: The radiochemical purity of the [(99mTc∫N)CysCysANX13] complex was
more than 90% both right after the labeling and after 24 h. The complex showed
specific uptake in apoptotic tumor cells.
Conclusion: Using the novel “nitrido-labelling” method resulted in a relatively high
radiochemical purity. Our stability examinations demonstrated the applicability of
the labelled peptide in the biological investigations.
RADIOPHARMACY
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SYNTHESIS OF O-(2-[18F]FLUOROETHYL)-L-TYROSINE: A CANDIDATE
FOR SATELITE DISTRIBUTION PET TRACER IN HUNGARY
G. Tóth1, Z. Oláh2, Z. Homonnay2
1Pozitron-Diagnosztika Ltd., Budapest, Hungary
2Laboratory of Nuclear Chemistry, Eötvös Loránd University, Budapest, Hungary
Aim: We aimed the synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) that could be
superior to FDG in characterization of primary brain tumors.
Material and methods: 18F was obtained from the EclipseHP cyclotron. The chemical
synthesis was carried out using TracerLab FXFN general purpose module. The
precursor compound chosen was obtained from ABX GmbH. TBA and Kriptofix2.2.2.
were tested as phase transfer catalysts. SepPak Light Silica cartridge and reversed
phase HPLC were used for purification.
Results: The protected tosyloxy-pecursor ensured one-step 18F-fluorination followed
by acidic deprotection in non-aqueous conditions. Catalysis with crown ether resulted
in higher fluorination yield (up to 87%) compared to tetrabutylammonium-ion
enforcement. Dry acetonitril gave the highest incorporation rate out of the polar
aprotic solvents tested. After cartridge-, and HPLC-purification the collected FET-
fraction was measured over 10 GBq (25–30% uncorrected yield).
Conclusion: L-[methyl-11C]methionine (MET) and FET are equivalent in clinical
usefulness, but making new PET-sites accessible by FET is an advantage that might
open wider applications for PET-amino acids in Hungary.
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RADIOPROTECTION
OCCUPATIONAL DOSE DUE TO INHALATION OF CONTAMINATED AIR
IN THE LABORATORY OF NUCLEAR MEDICINE
Klára Benedek1, Béla Kanyár2, István Szilvási1, Edit Takács1, Andrea Radácsi1
1Department of Nuclear Medicine, Kútvölgyi Clinical Unit, Semmelweis University,
Budapest, Hungary
2Radiation Protection Service, Semmelweis University, Budapest, Hungary
The radioactive concentration in the airspace of the laboratory was assessed from
the daily used radioactivity by a factor dependent on the type of chemical form
and medical test. The inhalation dose of occupational impact is provided by
the product of inhalation rate, activity concentration in air, duration of the stying in
the laboratory and the inhalation dose coefficient, separately to each of
the radionuclides used.
Taking into account the applied radionuclides, ventilation and other parameters
of the laboratory the average inhalation dose assessed to the staff, was 1.3 mSv.
The greatest contribution come from the Tc-99m used mainly in imaging diagnostics.
The part of Sm-153 (used to bone radiotherapy) provided nearly 30% of the total
inhalation dose. Other radionuclides (Ga-67, Tl-201, I-125 etc.) have a total
contribution less than 20%. The external dose determined by the national personal
dose network by film budget takes annually nearly 1 mSv, in average for
the laboratory.
Additionally the releases to the atnmospheric and aquatic environment have been
assessed from the activity concentration in air and intakes of patients staying in
the laboratory for 2–3 hours per investigation. The calculated releases was
approximately 10% of the limits given by the proper national standards.
PROMOTION OF RADIATION PROTECTION IN CLINICAL NUCLEAR
CARDIOLOGY
T. Sera1, 4, L. Csernay1, H. Gavaller2, L. Boda3, G. Szanto3, L. Kardos1, L. Pavics1, 4
1Euromedic Diagnostics Szeged Ltd, Szeged, Hungary
2Department of Cardiology, University of Szeged, Szeged, Hungary
3Cardiology Unit, County Hospital, Deszk, Hungary
4Department of Nuclear Medicine, University of Szeged, Szeged, Hungary
Background/Aim: Myocardial stress SPECT investigations are performed in our
nuclear medicine department on three days a week, on each day by a different
team, comprising a cardiologist and a technician. The aim of this study was to
investigate the radiation exposure experienced by the cardiologist teams participating
in the nuclear medicine work only in these 99m-Tc-MIBI stress studies.
Material and methods: Calibrated electronic personal dosimeters were used. The
data were processed with the aid of a computer program. The personal doses were
monitored for each team throughout 7 weeks, during 10 patient stress studies/day.
The working methods of the teams were analysed in connection with their radiation
exposure.
Results: The daily effective doses (mean ± SD) of the cardiologists were
9.25 ± 1.72, 16.16 ± 4.02 and 15.07 ± 3.3 microSv; of the technicians were:
9.74 ± 1.05, 12.67 ± 2.20 and 10.67 ± 3.0 microSv. The personal doses
of the cardiologists and technicians exhibited considerable differences.
Conclusion: The daily effective doses of the cardiologists and technicians performing
the same examinations can differ. Direct reading dosimeters are useful in planning
the optimal working methods and the infrastructure of the investigation rooms.
RIA
THE NOVEL RADIOIMMUNOASSAY METHOD FOR DETERMINING ACTIVE
RENIN
Nagy J. Kocsáné, T. Tóth, G. Császy
Department of Nuclear Medicine, Markhot Ferenc County Hospital, Eger,
Hungary
Aim: Up to now only the indirect determination of renin level was possible (by
calculating Plasma Renin activity from the value of angiotensin I). We have carried
out the comparative study and the automated application of the already purchasable
renin kit.
Material and methods: Daily routine samples were measured (altogether 42 plasma
samples) manually by Cisbio kits and by a Stratec 300 device. The results were
divided into low, normal and high value groups and the data were evaluated
biometrically.
Results: Our data correlated with each other in every group, considering the distinct
ranges of measurment (pg/ml and ng/ml), and the normal values given by the
producer.
Conclusions: 1. The measurement of angiotensin I — PRA is technically difficult, it
consists of two steps blank and generated sample, it requires incubation at 37°C. 2.
Active renin is a one-step method, which has to be performed at room temperature
and it can be automated easily. 3. Physiologically renin is the component responsible
for the capacity of the renin-angiotensin-aldosterone axle. 4. Replacing the current
angiotensin I — PRA measurements with active renin method seems to be reasonable
not only from clinical point of view, but either regarding measurement technology.
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IMPORTANCE OF RIA METHODS FOR IN VITRO DIAGNOSTICS
B. Schuman
Laborexpert Ltd., Budapest, Hungary
The aim of the presentation is to show importance and real function of RIA methods
with regard to a popular fallacy and false opinion.
The author presents and compares all notable characteristic (analytical sensitivity,
specificity, time of analysis, automation, parameter list, cost of measurement, etc.)
of RIA and non-RIA immunochemical methods. The presentation emphatically treats
clinical interpretation of analytical results. The lecture demonstrates international
data and expectable trends of application of RIA methods, and offers a suggestion
optimal application of RIA methods.
THERAPY
COMPARATIVE ANALYSIS OF THE RESULTS OF Y-90-EDTMP
AND SM-153-EDTMP TREATMENT OF PAINFULL BONE METASTASES
(MULTICENTRIC TRIAL)
I. Balogh1, Z. Nagy2, Szilvási3, P. Gál4, M. Bakos5, Z. Hajdú6,
T. Pásztor7, Z. Kopcsányi8, L. Zilahy9, L. Landherr10
1Department of Nuclear Medicine, Uzsoki Teaching Hospital, Budapest, Hungary
2Department of Nuclear Medicine, Jósa András Hospital, Nyíregyháza, Hungary
3Department of Nuclear Medicine, OGYK, Budapest, Hungary
4Department of Nuclear Medicine, Jávorszky Ödön Hospital, Vác, Hungary
5Department of Nuclear Medicine, Pándy Kálmán Hospital, Gyula, Hungary
6Department of Nuclear Medicine, Balassa János Hospital, Szekszárd, Hungary
7Department of Nuclear Medicine, Kenézy Gyula Hospital, Debrecen, Hungary
8Department of Nuclear Medicine, Péterfy S. u. Hospital, Budapest, Hungary
9Department of Nuclear Medicine, Kaposi Mór Teaching Hospital, Kaposvár,
Hungary
10Department of Oncology, Uzsoki Hospital, Budapest, Hungary
Aim: In advanced breast, prostate and lung cancer with multifocal osteoblastic
metastasis and intolerable bone pain we used Y-90-EDTMP (Y) and Sm-153-EDTMP
(Sm) for pain palliation. In this study our aim was to analyze: 1. The pain palliation
effect; 2. The type and severity of side effects; 3. The influence on the mass of
tumor. Finally: is there any significant difference between the two therapies.
Material and methods: We analysed the results of treated patients with
Y: 145 patients and with Sm: 35 patients measuring ad 1: the pain killing effect on
a 10 graded pain scale, ad 2: the number of red blood cells and platelets in every
two week during 3 months, ad 3: number and size of bone lesions on bone scans
performed before the therapy and after 3 months.
Results: We experienced ad 1: the pain killing effect with Y 128/145 cases (88%)
with Sm 32/35 cases (91%), ineffectiveness with Y was found in 17/145 cases (12%)
with Sm 3/35 cases (9%). Ad 2: As a late side effect the number of the red blood
cells and platelets decreased in every case, and improved spontaneously by
the 15th week. Ad 3: the reduction of the size of the metastases could be detected
by bone scan with Y in 14/145 cases (9%) with Sm 3/35 (8%).
Conclusions: The pain killing effect of both Y and Sm therapy proved to be very
high (Y: 88%, Sm 91%). We could not find any severe side effect. In addition to pain
palliation the Y and Sm therapy can decrease the mass of the metastases as well
(Y 9%, Sm 8%). Summarizing our results there was not any significant difference
between the Y and Sm therapy.
EXAMINATIONS OF RHENIUM [186RE] SULFIDE COLLOIDAL SUSPENSION
USED IN RADIOSYNOVECTOMY
A. Polyák, L. Balogh, D. Máthé, R. Kiraly, G. A. Jánoki
Department of Applied Radioisotopes, National “Frédéric Joliot-Curie”
Institute of Radiobiology and Radiohygiene, Budapest, Hungary
Aim: Localization and pharmacokinetics of therapeutical colloid
radiopharmaceuticals mainly depends on their particle sizes, the therapeutical effect
caused by the beta-emitter nuclide. In our experiments we examined biodistribution
of Rhenium [186Re] sulfide colloidal suspension after intra-articular injection.
Material and methods: Rhenium [186Re] sulfide colloidal suspension was
manufactured by CIS bio international. Animal model was New Zealand White Rabbit.
The samples were collected at 6 h, 24 h, and 3, 6, 10 and 15 days after injection with
five animals in each gorup.  Collected organs were blood, liver, lungs, kidneys,
stomach, spleen, left popliteal lymph, left inguinal lymph node, fat, muscle, bone
marrow, thyroid gland and contralateral tibia. Samples were placed in preweighed
plastic test tubes and their activity directly measured in the well-type gamma counter
and by Nucline X-Ring Gamma Camera. A group of organs were homogenised in
physiological saline, using an Ultra Turrax Homogeniser. Knee samples were
dissolved in aqua regia, a 3:1 volumetric mixture of cc. HCl and HNO3.
Results: Before measurements linearity, sensitivity and range of detection of
instruments was checked. Parallel mesurements proved to be able to keep a check
our reasults and to compare different sample processing methods. We didn't observe
any sample losses after homogenise of organs. We have not measured a
considerable activity in no other organ or tissue type. Only in a few animals were
presenting activities corresponding to 1–2% of the injected dose several days post
injection. Localization of radioactivity 24 h after administration of Rhenium [186Re]
sulfide colloid (percent of injected dose): injected knee: 92.86% (± SD = 5.75%),
liver: 0.87% (± SD = 0.13%), lungs: 0.03% (± SD = 0.01%), kidneys: 0.23% (± SD=
= 0.03%), blood: 0.17% (± SD = 0.04%). Gamma camera scans have proven that
main part of the injected radiopharmaceutical stays in the synovial space 15 days
post injection in rabbit knees.
Conclusions: Our experiments have shown that gamma radiation component of
beta emitting therapeutic isotopes offers a significant quantification advantage.
HISTOLOGICAL AND ARTHROSCOPICAL CHANGES AFTER YTTRIUM-90
ISOTOPE TREATMENT IN CHRONIC SYNOVITIS
M. Szentesi, I. Berkes, M. Vancsura
Chair of Rheumatology and Physiotherapy, Semmelweis University, Budapest, Hungary
Background: 4000 patients suffering from chronic synovitis were treated by Yttrium-
-90/Y-90/radiosynoviorthesis (RSO). Results were recorded with 70–80% as very
good or good. AIM: Our work aimed at examinig arthroscopic and tissue changes
as a result of successful radiosynoviorthesis.
Material and methods: 40 patients of them suffering from Rheumatoid Arthritis
(RA) were examined by arthroscop and arthroscopic-biopsy before Y-90 RSO, and
0.5–1 year or 2 years after the treatment.
Results: Before the treatment: The membrane is hyperaemic with grape-like clusters
proliferating. The surface was covered with several layers of synoviocyst with a diffuse
inflammatory infiltration beneath. After the treatment: Half a year later, no grape-like
clusters proliferating, the surface became silk-like. The surface was covered with
one layer of synoviocysts, inflammatory infiltration decreased, signs of fibrosis could
be seen. The histological picture remained unchanged even 1–2 years later. No
damages in cartilage could be seen. Spectral analysis did show no Y in the synovial
membrane and cartilage.
Conclusions: RSO was effective in 70–80% Parallel to the improvement of the clinical
pinture the macroscopic and microscopic signs of inflammation were decreasing.
membrane or cartilage contained no Y deposits.
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4-YEARS RESULTS WITH 166HOLMIUM-PHYTATE TREATMENT OF CHRONIC
SYNOVITIS. PHASE I–IIA, RANDOMIZED, INCREASING DOSAGE,
SINGLE-BLIND, PLACEBO-CONTROLLED COMPARATIVE STUDY
M. Szentesi1, S. Takács1, Z. Farbaky1, E. Nagy1, J. Környei2, M. Antalffy2, J. Törkõ2, P. Géher1
1Chair of Rheumatology and Physiotherapy, Department of Rheumatology, Polyclinic of
the Hospitaller Brothers of St. John of God, Semmelweis University, Budapest, Hungary
2Institute of Isotopes Co. Ltd., Budapest, Hungary
Aim: Examination of anti-inflammatory effect of 166-Holmium-phytate injection.
Material and methods: Phases I–II, randomized, simple-blind, placebo-controlled comparative study
using increasing dosage. 31 patients suffering from chronic synovitis, rheumatoid arthritis and seronegative
spondylarthritis were examined. Gender (male/female): 12–19; Diagnosis (RA/SNSA): 21/10; Stage of
knee joint X-ray (I/II): 7/24; Duration of synovitis (years): 7.9; Duration of disease (years): 5.72; Number of
punctures before the Ho-166 treatment: 18.76; Number of steroid injections before the treatment: 18.85.
The protocol commenced with screening. Patients were randomly distributed into four treatment arms:
— group I — holmium phytate injectable suspension marked by 185 MBq 166Ho + 40 mg of 1 ml
triamcinolone acetonide (TA) + 1 ml of 1% lidocaine injection (Lid. inj.);
— group II — 555 MBq 166Ho. + 40 mg of 1 ml TA + 1 ml Lid. inj.;
— group III — 925 MBq 166Ho + 40 mg 1 ml TA + 1 ml of 1% Lid. inj.;
— group IV — solely 40 mg of 1 ml TA + 1 ml of 1% Lid. inj.
There were 48 month follow-up period after the administration of the isotope. Inflammatory activity
of the affected knee-joint was tested prior to treatment, and the 14th and 28th days, and 3, 6, 9, 12,
24, 36 and 48 months after treatment. Testing was done based on the following parameters:
Measurement of swelling of knee-joint [cm]; Flexion – heal buttocks distance [cm]; Degree of knee-
joint pain. Visual Analogue Scale (VAS-1-100); Patient's opinion on inflammation of knee-joint
(VAS-1-100); Doctor's opinion on given inflammation of knee-joint (VAS-1-100).
Results: Even after 4 year period 88.2% of the findings were rated as excellent or good. 86.66% of
the patients do not need another punction even after a 4 years period. We found no deviations in
either haematological or chemical parameters during the study period. Administration of
Holmium-166 phytate is a safe procedure. We did not detect symptoms of radiation sickness.
During the study period, inflammation decreased in the group receiving 555 and 925 MBq.
Conclusion: Ho-166 isotope is an effective radiopharmacy treating synovitis. Due to its physical
parameters it is optimal to treat large joints (knee) and medium size joints (hips, shoulder, elbow,
wrist, ankle). Effective dosage is 555–925 MBq.
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166HOLMIUM-PHYTATE-RADIOSYNOVIORTHESIS IN RHEUMATOID ARTHRITIS.
TWO YEARS CLINICAL RESULTS. PHASE III PROSPECTIV STUDY.
M. Szentesi1, S. Takács1, Z. Farbaky1, E. Nagy1, J. Környei2, M. Antalffy2, J. Törkõ2, P. Géher1
1Chair of Rheumatology and Physiotherapy, Department of Rheumatology, Polyclinic of
the Hospitaller Brothers of St. John of God, Semmelweis University, Budapest, Hungary
2Institute of Isotopes Co. Ltd., Budapest, Hungary
Background: The first article on radiosynoviorthesis was published in 1952 by Fellinger. The traditional
isotopes cause whole body radiation of 10 Rad. Isotope specialists have aspired to produce an
isotope incurring lower radiation loads. (Pirick, Russel, Sledge, Junsing Song).
166-Holmium-phytate produced by us: radiation type beta energy maximum: 1.84 MeV; radiation
type gamma energy maximum: 0.66 MeV; soft tissue penetration: maximum 8.4 mm; average: 3.3
mm; half-life: 26.9 hours; particle size: 0.6–2 mm.
Aim: Examination of anti-inflammatory effect of 166-Holmium-phytate injection.
Material and methods: Phases III, prospectiv study. 30 patients suffering from chronic synovitis,
rheumatoid arthritis were examined. The protocol commenced with screening. The patients were
selected according to inclusion and exclusion criteria. Gender (male/female): 7–23; age: 57.13 ±
± 9.87 (37–77); stage of knee joint X-ray (I/II): 7/23; duration of synovitis (years): 7.38 ± 7.21(0.5–27);
duration of disease (years): 9.1 ± 8.01 (1–27); number of punctures before the Ho-166 treatment:
12.8 ± 25.98 (3–150) Number of steroid injections before the treatment: 12.9 ± 25.93 (3–150). Holmium
phytate injectable suspension marked by 600 MBq 166Holmium phytate injectable suspension, and 40
mg of 1 ml triamcinolone acetonide and 1 ml of lidocaine 1%. There were 24 month follow-up period
after the administration of the isotope. Inflammatory activity of the affected knee-joint was tested prior
to treatment, and the 3rd and 3, 6, 9, 12 and 24 months after treatment. Evaulation was based on the
criteria as described by Müller, Rau and Scütte the score system was developed by the authors.
Results: During the study period, inflammation decreased. In the first two years excellent and good
results were recorded in 93.3%. Two year after radiosynoviorthesis 93.3% of patients did not need
another punction. Administration of Holmium-166 phytate is a safe procedure. We did not detect
any symptoms of radiation sickness. We found no deviations in either haematological or chemical
parameters during the study period.
Conclusion: Holmium-166 phytate isotope is an effective radiopharmacy treating synovitis. Due its
adventageous features it produces less radioactive damage on the organism than the traditionally used
isotopes (90-Yttrium, 169-Erbium, 186-Rhenium). Due to its physical parameters it is optimal to treat large
joints (knee) and medium size joints (hips, shoulder, elbow, wrist, ankle). Effective dosage is 555–925 MBq.
References
Szentesi M. Radiosynoviorthesis with Ho-166 phytate. First clinical results. EANM Post-Congress Scintific Meeting.
Radionuclide therapy in theory and practice. Gyõr, Hungary. 5 September 2002.
Szentesi M, Környei J, Antalffy M, Törkõ J, Tóth G, Jánoki G, Balogh L. Study of intraarticular application of
166-Holmium IHPP in rabbits. World J Nucl Med 2002; 1 (suppl 2): S243.
Szentesi M, Takács S, Farbaky Z, Nagy, Környei J, Antalffy M, Törkõ J, Tóth G, Jánoki G, Balogh L, Géher P.
Comparitive study of applying increasing doses of 166Ho-phytate injectable suspension in chronic synovitis.
(Comparative, randomized, single-blind, placebo-controlled study with increasing dosage). Eur J Nucl Med
2003; Suppl 2: 498.
Szentesi M, Takács S, Farbaki Z, Nagy E, Környei J, Antalffy M, Törkõ J, Tóth G, Jánoki G, Balogh L, Géher P.
Radiosynoviorthesis with 166Ho-phytate — First clinical results. Phase I-IIa, randomized, increasing dosage, single-
blind, placebo-controlled comparative study. Eur J Nucl Med 2003; Suppl 2: 500.
Szentesi M, Farbaky Z, Budai I, Bálint B, Géher P. Monitoring the synovial thickness after 166-Holmium-phytate
radiosynoviorthesis by sonography. Nuclearmedicin 2003; 42: 179–180.
ULTRASOUND MONITORING OF THE SYNOVIAL THICKNESS AFTER
166-HOLMIUM-PHYTATE RADIOSYNOVIORTHESIS — TWO YEARS
RESULTS. PHASE III PROSPECTIVE STUDY
M. Szentesi1, Z. Farbaky2, P. Géher1
1Chair of Rheumatology and Physiotherapy, Department of Rheumatology, Polyclinic
of the Hospitaller Brothers of St. John of God, Semmelweis University, Budapest, Hungary
2Institute of Isotopes Co. Ltd., Budapest, Hungary
Background: The first article on radiosynoviorthesis was published in 1952 by Fellinger. The traditional
isotopes cause whole body radiation of 10 Rad. Isotope specialists have aspired to produce an
isotope incurring lower radiation loads. (Pirick, Russel, Sledge, Junsing Song).
166-Holmium-phytate produced by us: radiation type beta energy maximum: 1.84 MeV; radiation
type gamma energy maximum: 0,66 MeV; soft tissue penetration: maximum 8.4 mm; average:
3.3 mm; half-life: 26.9 hours; particle size: 0.6–2 mm.
Aim: Measure the synovial thickness after 166-Holmium radiosynoviorthesis by sonography.
Material and methods: Phases III, prospective study. 30 patients suffering from chronic synovitis,
rheumatoid arthritis were examined. The protocol commenced with screening. The patients were selected
according to inclusion and exclusion criteria. Gender (male/female): 7-23; age: 57.13 ± 9.87 (37–77);
stage of knee joint X-ray (I/II): 7/23; duration of synovitis (years): 7.38 ± 7.21 (0.5–27); duration of
disease (years): 9.1 ± 8.01 (1–27); number of punctures before the Ho-166 treatment: 12.8 ± 25.98 (3–
–150); number of steroid injections before the treatment: 12.9 ± 25.93 (3–150).
Holmium phytate injectable suspension marked by 600 MBq 166Holmium phytate injectable suspension,
and 40 mg of 1 ml triamcinolone acetonide and 1 ml of lidocaine 1%. There were 24 month follow-up
period after the administration of the isotope. Inflammatory activity of the affected knee-joint was tested
prior to treatment, and 3, 6, 12 and 24 months after the treatment. We measured the synovial thickness
the following locations: In the midline, lateral and medial, by the condylus of femur medial and lateral.
Results: During the study period, inflammation decreased. In the first two years excellent and good
results were recorded in 93.3%. Two years after radiosynoviorthesis 93.3% of patients did not need
another punction. The thickness of the synovia decreased significantly. We find a significant correlation
between the synovial thickness and the clinical improvement.
Conclusion: The 166-Holmium-phytate is an effective new radiopharmaceutical in the treatment of
synovitis. We detect the clinical improvement by sonography. The effective dose is 555–925 MBq.
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ULTRASOUND MONITORING OF THE SYNOVIAL THICKNESS AFTER
166-HOLMIUM-PHYTATE RADIOSYNOVIORTHESIS: FOUR-YEARS
RESULTS (COMPARATIVE, RANDOMIZED, SINGLE-BLIND,
PLACEBO-CONTROLLED STUDY WITH INCREASING DOSAGE)
M. Szentesi, S. Takács, I. Buday, M. Nyitrai, E. Nagy, P. Géher, Z. Farbaky
Chair of Rheumatology and Physiotherapy, Department of Rheumatology, Polyclinic of
the Hospitaller Brothers of St. John of God, Semmelweis University, Budapest, Hungary
Background: 166-Holmium-phytate has a: radiation type beta energy maximum: 1.84 MeV;
and radiation type gamma, energy maximum: 0.66 MeV; soft tissue penetration: maximum
8.4 mm; (average: 3.3 mm); half-life: 26.9 hours; particle size: 0.6–2 mm.
Aim: measur the synovial thickness after 166-Holmium radiosynoviorthesis by sonography.
Material and methods: Phase I–II, randomized, simple-blind, placebo-controlled comparative
study using increasing dosage. 31 patients suffering from chronic synovitis, rheumatoid
arthritis, or seronegative spondylarthritis were examined. Gender (male/female): 12–19;
Diagnosis (RA/SNSA): 21/10; Stage of knee joint X-ray (I/II): 7/24; Duration of synovitis (years):
7.9; Duration of disease (years): 5.72; Number of punctures before the Ho-166 treatment:
18.76; Number of steroid injections before the treatment: 18.85.
The protocol commenced with screening. The patients were selected according to inclusion
and exclusion criteria. Patients were randomly distributed into four treatment arms:
— group I — 185 MBq 166Holmium phytate injectable suspension and 40 mg of 1 ml
triamcinolone acetonide, and 1 ml of lidocaine injection 1%;
— group II — 555 MBq 166Holmium phytate injectable suspension, and 40 mg of 1 ml
triamcinolone acetonide and 1 ml of lidocaine 1%;
— group III — 925 MBq 166Holmium phytate injectable suspension and 40 mg of 1 ml
triamcinolone acetonide and 1 ml of lidocaine 1%;
— group IV — solely 40 mg of 1 ml triamcinolone acetonide and 1 ml of lidocaine injection 1%.
There were 48 month follow-up period after the administration of the isotope. We measured
the quantity of the synovial fluid and the thickness of the synovia before the treatment, and
the 14th, 28th days and 3, 6, 9, 12, 24, 36 and 48 months after the treatment. We measured the
synovial thickness the following locations: In the midline, lateral and medial, by the condylus
of femur medial and lateral.
Results: The thickness of the synovia decreased significantly in the group II. (555 MBq) and
III. (925 MBq). After a transient improve (the steroid effect) the thickness of the synovia
began to rise in the group I. (185 MBq) and in the control group. We find a significant correlation
between the synovial thickness and the clinical improvenes.
Conclusion: The 166-Holmium-phytate is an effective new radiopharmacon in the treatment
of synovitis. We detect the clinical improvement by sonography. The effective dose is 555–925 MBq.
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TEN YEARS RESULTS OF YTTRIUM-90 RADIOSYNOVIORTHESIS
IN CHRONIC KNEE SYNOVITIS OF DIFFERENT ORIGIN
M. Szentesi, S. Takács, M. Vancsura
Chair of Rheumatology and Physiotherapy, Semmelweis University, Budapest, Hungary
Background: Authors report on the results of Yttrium-90 radiosynoviorthesis in chronic synovitis
of the knee joint.
Aim: Examination of anti-inflammatory effect of 90-Yttrium injection.
Material and methods: Out of these 617 patients 366 suffered from rheumatoid arthritis,
51 ankylosing spondylitis, 39 other seronegative spondylarthritis, 144 suffered from inflamed
osteoarthritis , 3 hydrops articulorum intermitterns, 3 synovitis villonodularis, 11 from chronic
traumatic synovitis. Evaulation was based on the criteria as described by Müller, Rau and
Scütte the score system was developed by the authors.
Results: In the first ten years excellent and good results were recorded in 71%. They achieved
excellent as well as good results at 83% of patients with rheumatoid arthritis, at 50% of patients
with ankylosing spondylitis and at 55% of patients with osteoarthritis. Ten years after
radiosynoviorthesis 72% of patients did not need another punction.
Conclusions: Radiosynoviorthesis is as effectiv method of treating chronic synovitis as surgical
synovectomy. Even after a ten-years period 71% the findings were rated as excellent or good.
72% of the patients do not need another punction even after a ten years period. The
effectiveness is worsened significantly by the stadium of the disorder and the local X-ray
phase and diagnosis. P 0.00001. The treatment must be done in rheumatoid arthritis
Steinbrocker stadium I–II, local stadium I–II.
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RESULTS OF ONE YEAR  FOLLOW-UP — RADIOSYNOVECTOMY
IN KNEE AND HIP JOINT
I. Szerb1, C. Komora2, G. Kovács2, I. Balogh2
1Uzsoki Street Teaching Hospital Orthopedics, Budapest, Hungary
2Department of Nuclear Medicine, Budapest, Hungary
Aim: One year follow-up results of 65 pts treated with radiosynovectomy were
evaluated. In 17/65 cases the hip and in 46/65 cases the knee were treated.
Material and methods: The indication of radiosynovectomy was synovitis in systemic
disease (PCP, SNSA, psoriatic arthritis) in 21/65 cases or in  early stage of arthrosis
in 41/65 cases. Mean age was 49 year (30-82), 51 female, 14 male. Before the
treatment X-ray examinations, 3 phase bone scintigraphy and ultrasonography were
made in every case. Yttrium-90-colloid was used for radiosynovectomy of hip and
Rhenium-186-colloid for radiosynovectomy of knee. Measurement of clinical
improvement was performed with HSS (Hospital for Special Surgery) score. 3 phase
bone scintigraphy and ultrasonography were repeated after 3–6 months.
Results: On the basis of clinical improvement our cases were divided into 3 groups:
1. best clinical effect (HSS score 80–100), 2. intermediate therapeutical  effect (HSS
score 60–80), 3. low therapeutical effect (HSS score 40–60). We could register in
52/65 (80%) of patients clinical  improvement 1.–3. score in HSS score system with
improved mobility, pain, inflammation, oedema. Ultrasonography and 3 phase bone
scintigraphy had good correlation with the clinical status.
Conclusion: On the basis of objective clinical scoring, and results of diagnostic
procedures (3 phase bone scintigraphy and ultrasonography) radiosynovectomy
of hip and knee was proved to be a good alternative method for the treatment of
synovitis.
VETERINARY NUCLEAR MEDICINE
HUNGARIAN EXPERIENCES WITH THE TREATMENT OF CANINE
OSTEOSARCOMA CASES
L. Balogh1, G. Andócs1, D. Máthé1, A. Polyák1, R. Király1, P.R. Chaudhari2,
T. Das2, P. Vajdovich3, D. Szécsényi3, J. Thuroczy3, N. Oppe3, G.A. Jánoki1
1Department of Applied Radioisotopes National “F.J.C.” Research Institute
for Radiobiology and Radiohygiene, Budapest, Hungary
2Bhabha Atomic Energy Institute, Mumbay, India
3Szt István Egyetem, Állatorvos-tudományi Kar, Budapest, Hungary
Aim: The diagnosis of canine primary bone tumors is relativelly simple but therapy
is still nowadays not eligible. The basic problem is that at the time of occurance of
symptoms and diagnosis in most of the patients multiple soft tissue and/or bone
metastases are present. A further problem is that osteosarcoma in humans and in
dogs is so called therapy-resistant tumor type so it is not responding for the known
chemo-, or radiation therapy protocols.
Material and methods: In our Institute we have been diagnosed nearly 600
osteosarcoma dogs in the last 10 years — from these altogether 84 appendicular
osteosarcoma dogs were treated and followed-up properly. The treatment protocols
were as follows:
— group I — amputation + chemotherapy;
— group II — local radiotherapy + chemotherapy;
— group III — only chemotherapy;
— group IV — only NSAIDs.
After treatment survival times and side effects were recorded, and size changes of
primary and metastatic tumors were investigated by 3-phase bone scintigraphy
and X-ray, and laboratory parameters, changes in the body-weight, and lameness
parameters (Batemann scores, diameter and flexibility of the joints). Results of the
therapy of different groups were evaluated statistically.
Results: In the group IV. the shortest survival and greatest weight-loss was found
but there were only mild side effects and no one pathological fractute. Patients of
groups I., II., and III showed the longer survival times and paralell ythe more sever
side-effects (no significant difference among them).
Conclusion: On the base of our experiences we can conclude the further
development of osteosarcoma treatments is a need. We believe that local
hyperthermia, liposoma encapsulated drugs and radiolabelled compounds could
be the choices for novel protocols.
STUDIES ON 177LU-EDTMP BIODISTRIBUTION IN TUMOROUS ANIMALS
D. Máthé, R. Király, G. Jánoki, L. Balogh, A. Polyák
Department of Applied Radioisotopes, National “Frédéric Joliot-Curie” Institute
of Radiobiology and Radiohygiene, Budapest, Hungary
Aim: Preclinical studies on 177Lu-EDTMP in spontaneous dog tumors. Determination
of pharmacokinetic parameters, assay of biological effects and side effects.
Material and methods: Following radiolabelling and quality control to study tumor
uptake, 4 naturally occurring tumorous dogs (3 osteosarcoma, 1 bone metastasis
form unknown origin) were inejcted with 44.4 MBq/bwkg, and clinical status, blood
counts, biochemistry and gamma camera scans. At each study dosimetry was
performed using OLINDA 1.0.
Results: In dogs, a high bone uptake is also present (cca. 50% after 1 week).
A variable bone tumor uptake was observed depending on bone remodeling activity,
calculated tumour dose fell in the range of 0.58–15.7 Gy. In one case (metastasis,
calculated tumor dose: 4.7 Gy) stable disease and long term clinical improvement
was oberved, in the other 3 cases (osteosarcomas) animals had to be euthanised
in a month due to progression.
Conclusions: 177Lu-EDTMP radionuclide therapy (RNT) is based on an appropriate
bone uptake of the radiopharmaceutical. Radiotoxicological profile in dogs shows
significant advantages as no white blood cell count decrease was observed at the
injected high activity. Originally aimed therapy of metastases is well feasible and
realistic and can easily be modelled in spontaneous dog tumours. To obtain
a therapeutic tumor dose for osteosarcoma (over 60 Gy) increased activity dosing
or application of additive modalities is necessary. Assessment of radiation sensitivity
of the tumor prior to RNT could be a key of successful antitumor therapy beyond
palliative effects as well.
Acknowledgement: EC-FP6 EMIL Network of Excellence.
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MULTIPLE ENDOCRINE DEPENDENT TUMORS IN A DOG PATIENT
WITHOUT MEASURABLE ENDOCRINE CONSEQUENCES
J. Thuróczy1, N. Oppe1, A. Tibold1, L. Balogh2, G. Andócs2, D. Máthé2,
P.R. Chaudhari3, T. Das3, G.A. Jánoki2
1Szt István University, Veterinary Faculty, Budapest, Hungary
2Department of Applied Radioisotopes, National “F.J.C.” Research Institute
for Radiobiology and Radiohygiene, Budapest, Hungary
3Bhabha Atomic Energy Institute, Mumbay, India
Testicular neoplasmas are 5–15 percent of total tumours number in male dogs.
Seminomas are the most common type of testicular tumours in dog.
The thyroid tumours are large, unilateral palpable masses in neck region in most of
the cases. Although seventy percent of malignant thyroid neoplasms are carcinomas,
5–20% of them are endocrinologically active which induce the clinical signs of
hyperthyroidism.
Seven — twenty one percent of skin tumours are mastocytomas in dog but the
incidence of them is higher in spayed female and intact male dogs which should
indicate the testosterone dependency.
Eight years old argentin dog was present at our clinic with clinical signs of alopecia,
weight loss and ointment faeces. Plasma biochemical parameters were in reference
ranges. The total thyroxin concentration was 30.11 nmol/l which is fit to euthyroid
state. An altered density focus in right testis was visualized by the ultrasonographic
examination. Neither testosterone nor estrogen serum concentrations were high.
The Tc-pertechnetate uptake of left thyroid gland was increased in opposite the
visualisation of right thyroid gland was decreased. The left thyroid gland, both testes
and an 1 cm diameter nodule in skin were surgically removed.
Seminoma in both testes, follicular compact cell carcinoma and C-cell carcinoma in
removed thyroid gland and Grade-II type mastocytoma in skin were histologically
established.
The faeces got the normal consistency following the operation. The hair grows
finished in sixth week after the operation and the bodyweight increased with 8
kilogram. The thyroxin concentration after transient decrease reached the 35.48
nmol/l level in four month. Plasma TSH concentration was 0.272 ng/ml.
The combination of three different endocrine tumours with a suspected hormone
dependent tumour suggests the relation of their development. In spite of hormone
dependent tumours the plasma hormone levels were ambiguous and reached to
diagnosis with use of complex diagnostic imaging techniques.
AEROSOL LUNG VENTILLATION STUDIES IN LABORATORY RABBIT MODEL
FOR NEW VETERINARY PULMONARY DRUG / VACCINE DEVELOPMENT
J.J Parmar1, D.M Menon1, R.V. Gaikwad2, P.R. Chaudhary3, A. Samad2,
L. Balogh4, G. Janoki4
1Department of Pharmaceutics, Bombay College of Pharmacy, Kalina, Mumbai, India
2Veterinary Nuclear Medicine Center, Bombay Veterinary College, India
3Laboratory Nuclear Medicine Section, BARC, Mumbai, India
4National "Frederic Joliet Curie" Institute of Radiobiology and Radiohygiene,
Budapest, Hungary
Radioisotope techniques are used routinely in human pre-clinical drug development.
These techniques include in vivo and in vitro studies. Nuclear scintigraphy procedures
are used to evaluate various pharmaceutical preparations for their distribution pattern,
uptake and excretion. The most suitable radionuclide is 99mTechnetium, which has
short half-life of six hours and gamma energy of 140 keV, suitable for in vivo detection.
The objective of this study was to carryout lung ventilation with aerosol of 99mTc-
-labeled Etoposide liposomes. Etoposide is a semisynthetic epiodophyllotoxin
derivative used as anticancer drug against pulmonary primary and secondary lesions.
The normal healthy laboratory New Zealand White rabbits were used. Etoposide
loaded liposomes were labeled with 99mTc using reducing agent, stannous chloride.
The preparation was used immediately to form aerosol using ultrasonic nebulizer in
isolated area to avoid aerial contamination while imaging. The imaging was performed
at 2, 4, 8 and 12 hours post inhalation.
The percent uptake of labeled liposome inhalation was calculated in central and
peripheral lung regions. In right central region uptake was found to be 33.72, 34.80,
31.82, 30.46 percent at 2, 4, 8 and 12 hours post inhalation respectively, whereas in
left region uptake percentage was 30.84, 29.68, 27.81 and 25.43 respectively.
In right peripheral region uptake was 66.28, 65.20, 68.18, and 69.54 percent at 2, 4,
8 and 12 hours post inhalation respectively, whereas in left region uptake percentage
was 69.16, 70.32, 72.19 and 74.57 respectively. The ratio of central to peripheral
region of right lung was 0.51, 0.53, 0.47, and 0.44, whereas at left lung it was 0.45,
0.42, 0.39 and 0.34 at 2, 4, 8 and 12 hours post inhalation respectively. This animal
model of aerosol inhalation was found to be very useful in providing kinetics of the
labeled compound non-invasively. This report suggests a huge potential in use
of scintigraphy procedures for drug development for pulmonary targeting.
